data_2ksz_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ksz _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 48.2 mt . . . . . 0 N--CA 1.455 -0.181 0 CA-C-O 120.938 0.399 . . . . 0.0 110.404 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.404 ' O ' ' N ' ' A' ' 8' ' ' GLN . 0.3 OUTLIER -92.99 125.91 37.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.449 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.467 ' O ' ' N ' ' A' ' 9' ' ' ILE . 80.7 tt0 -37.3 -72.47 0.06 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.281 0.562 . . . . 0.0 111.621 -179.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -47.51 -28.85 2.4 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.947 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.404 ' N ' ' O ' ' A' ' 5' ' ' SER . 44.9 tt0 -79.42 -24.65 42.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.399 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.467 ' N ' ' O ' ' A' ' 6' ' ' GLU . 3.4 tp -68.51 -36.92 76.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.3 t -75.23 -44.6 42.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.022 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -54.95 -50.24 69.39 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.642 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -66.52 -44.09 83.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.295 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -56.54 -42.74 78.99 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.404 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.9 tp10 -58.76 -46.09 88.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.367 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.92 -30.64 69.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.454 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -69.24 -48.95 60.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.853 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -65.82 -30.1 76.48 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 44.1 mt -72.74 -40.58 65.96 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.487 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -87.45 -15.2 38.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.481 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -113.82 101.82 9.64 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 110.213 -0.292 . . . . 0.0 110.213 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.512 ' C ' ' H ' ' A' ' 23' ' ' GLY . 55.2 mtpt -109.89 -31.68 7.32 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.011 0.434 . . . . 0.0 110.508 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.509 ' C ' ' H ' ' A' ' 24' ' ' ASP . 38.2 p30 -44.78 -15.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.554 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.512 ' H ' ' C ' ' A' ' 21' ' ' LYS . . . 69.18 -10.15 1.9 Allowed Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.509 ' H ' ' C ' ' A' ' 22' ' ' ASP . 35.6 p-10 -50.37 -11.61 0.08 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.743 0.306 . . . . 0.0 110.476 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.505 ' H ' ' C ' ' A' ' 23' ' ' GLY . . . 75.8 -70.51 2.0 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 60.4 m -70.08 169.82 12.68 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.078 0.466 . . . . 0.0 110.767 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.44 ' O ' ' O ' ' A' ' 63' ' ' ILE . 6.3 pt -138.24 165.0 26.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.362 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 49.8 p -86.45 -170.95 3.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.493 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 72.5 t -79.44 -36.81 18.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.5 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -64.57 -50.02 68.88 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.733 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -42.24 -62.1 1.02 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.588 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.65 -39.65 89.13 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.475 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -44.19 -67.98 0.24 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.11 0.481 . . . . 0.0 110.426 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 19.6 m -49.19 -51.4 33.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.749 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 89.7 t -50.79 -30.76 9.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.693 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -68.42 -35.72 71.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -67.64 -42.74 81.77 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.628 -0.429 . . . . 0.0 111.022 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.1 p -67.82 -39.2 83.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.784 0.326 . . . . 0.0 110.897 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.454 ' O ' ' N ' ' A' ' 41' ' ' GLN . 52.7 mt -61.26 125.45 23.8 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.994 0.426 . . . . 0.0 109.999 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -65.22 66.19 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.826 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.485 ' C ' ' ND2' ' A' ' 42' ' ' ASN . 37.3 tt0 -140.48 173.55 11.39 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.146 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.485 ' ND2' ' C ' ' A' ' 41' ' ' GLN . 0.4 OUTLIER -143.33 67.34 16.69 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.749 0.309 . . . . 0.0 110.346 -179.89 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -83.13 143.06 11.2 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.681 2.254 . . . . 0.0 111.995 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 31.5 p -64.47 130.59 44.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.374 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -71.81 -36.61 70.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.63 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -49.2 -41.98 38.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.332 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -58.59 -57.6 12.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.498 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.426 ' N ' ' CD1' ' A' ' 48' ' ' LEU . 9.6 mp -43.62 -46.42 7.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.546 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -57.56 -48.59 78.92 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.295 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -64.07 -50.76 67.09 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.183 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.531 ' O ' ' N ' ' A' ' 55' ' ' VAL . 65.6 mmm -63.45 -65.46 0.68 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.33 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 39.1 mm -44.79 -46.59 2.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.3 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.3 t -73.55 -20.34 60.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.594 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' A' ' 51' ' ' MET . 34.6 tt0 -106.59 8.83 31.43 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.785 0.326 . . . . 0.0 110.701 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.531 ' N ' ' O ' ' A' ' 51' ' ' MET . 75.0 t -124.09 -36.49 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 120.811 0.339 . . . . 0.0 110.442 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.4 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 32.4 t0 -54.35 86.15 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.628 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -73.89 -49.41 25.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.41 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.429 ' OD2' ' OE1' ' A' ' 64' ' ' GLU . 17.1 m-20 -48.94 -28.57 3.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.45 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.83 12.04 84.9 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.518 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 28.3 p30 -90.29 -0.77 57.78 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.783 0.325 . . . . 0.0 110.531 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.4 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 64.16 40.83 98.4 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.518 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 54.4 p -136.93 152.23 49.95 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.848 0.356 . . . . 0.0 110.406 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.44 ' O ' ' O ' ' A' ' 27' ' ' ILE . 82.3 mt -87.89 153.07 3.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.342 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.429 ' OE1' ' OD2' ' A' ' 58' ' ' ASP . 57.0 mt-10 -142.12 179.52 6.85 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.347 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -52.91 -79.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.475 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -44.46 -53.26 7.11 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.493 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -49.04 -38.0 22.5 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.719 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 65.4 t80 . . . . . 0 C--N 1.327 -0.379 0 C-N-CA 120.884 -0.327 . . . . 0.0 110.877 179.911 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 46.6 mt . . . . . 0 N--CA 1.454 -0.26 0 CA-C-O 120.875 0.369 . . . . 0.0 110.396 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.432 ' O ' ' N ' ' A' ' 8' ' ' GLN . 0.2 OUTLIER -99.8 126.7 45.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.36 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.443 ' O ' ' N ' ' A' ' 9' ' ' ILE . 80.2 tt0 -36.69 -72.11 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.138 0.494 . . . . 0.0 111.571 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -47.71 -28.54 2.5 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.929 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.432 ' N ' ' O ' ' A' ' 5' ' ' SER . 44.0 tt0 -79.76 -25.99 40.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.475 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.443 ' N ' ' O ' ' A' ' 6' ' ' GLU . 3.2 tp -67.25 -36.27 76.27 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 61.7 t -76.02 -44.36 37.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.913 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -55.2 -49.87 70.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.743 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -66.93 -43.97 81.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.365 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -57.04 -42.72 80.98 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.815 0.34 . . . . 0.0 110.366 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.1 tp10 -58.96 -45.13 91.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.377 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.8 -31.6 70.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.43 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.421 ' O ' ' N ' ' A' ' 20' ' ' ASP . 28.9 t80 -69.01 -49.76 54.85 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.814 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -63.66 -31.58 81.25 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 46.5 mt -71.8 -40.03 69.47 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.48 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -87.29 -15.83 36.9 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.513 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.421 ' N ' ' O ' ' A' ' 16' ' ' PHE . 30.2 t70 -114.06 102.19 9.94 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 179.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.508 ' C ' ' H ' ' A' ' 23' ' ' GLY . 55.5 mtpt -110.45 -31.23 7.34 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.942 0.401 . . . . 0.0 110.547 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.503 ' C ' ' H ' ' A' ' 24' ' ' ASP . 35.8 p30 -45.19 -15.61 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.575 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.508 ' H ' ' C ' ' A' ' 21' ' ' LYS . . . 68.47 -8.96 1.92 Allowed Glycine 0 CA--C 1.523 0.54 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.503 ' H ' ' C ' ' A' ' 22' ' ' ASP . 43.6 p-10 -51.93 -11.6 0.17 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.86 0.362 . . . . 0.0 110.545 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.473 ' H ' ' C ' ' A' ' 23' ' ' GLY . . . 75.34 -70.49 1.88 Allowed Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 57.3 m -69.29 169.19 12.69 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.177 0.513 . . . . 0.0 110.579 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.7 pt -138.43 165.06 25.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.18 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.491 ' H ' ' HG1' ' A' ' 28' ' ' THR . 0.2 OUTLIER -87.28 -171.23 3.38 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.117 179.946 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.1 t -79.08 -37.25 19.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.458 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.0 -50.22 69.36 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.669 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -42.25 -62.27 0.99 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.542 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.56 -39.54 88.34 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.47 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -44.52 -68.05 0.23 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.146 0.498 . . . . 0.0 110.317 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.6 m -48.62 -51.65 27.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.808 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 86.2 t -50.62 -31.87 9.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.694 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -67.2 -35.58 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -68.03 -42.61 80.33 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.951 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.0 p -68.01 -38.68 82.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.87 0.367 . . . . 0.0 110.818 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.456 ' O ' ' N ' ' A' ' 41' ' ' GLN . 55.9 mt -61.41 124.15 19.82 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.912 0.386 . . . . 0.0 110.099 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -64.93 66.83 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.754 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.487 ' C ' ' ND2' ' A' ' 42' ' ' ASN . 37.2 tt0 -141.0 173.75 11.17 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.122 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.487 ' ND2' ' C ' ' A' ' 41' ' ' GLN . 0.4 OUTLIER -143.43 67.41 16.54 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.823 0.344 . . . . 0.0 110.419 -179.925 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -83.09 143.38 11.4 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.769 2.313 . . . . 0.0 112.096 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 40.6 p -65.87 132.41 48.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.345 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -72.16 -34.49 68.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.642 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -51.33 -44.55 62.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.453 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -57.28 -59.86 4.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.569 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.413 ' N ' ' CD1' ' A' ' 48' ' ' LEU . 9.6 mp -44.33 -46.06 9.08 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.467 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -57.9 -47.41 82.87 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.424 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -64.14 -50.77 66.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.158 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.554 ' O ' ' N ' ' A' ' 55' ' ' VAL . 77.2 mmm -63.67 -63.63 1.12 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.333 -179.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 31.3 mm -43.37 -47.42 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.336 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.8 t -71.92 -21.8 61.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.691 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.501 ' N ' ' O ' ' A' ' 51' ' ' MET . 53.2 tt0 -107.21 9.19 30.25 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 120.823 0.344 . . . . 0.0 110.578 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.554 ' N ' ' O ' ' A' ' 51' ' ' MET . 73.2 t -123.09 -38.38 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-O 120.839 0.352 . . . . 0.0 110.385 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -55.02 85.55 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.481 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -72.05 -50.05 31.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.447 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.427 ' OD2' ' OE2' ' A' ' 64' ' ' GLU . 17.4 m-20 -47.05 -28.59 1.76 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.412 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.83 10.33 86.12 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.934 -0.867 . . . . 0.0 110.934 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.52 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 36.3 p-10 -89.49 -1.87 58.18 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.773 0.32 . . . . 0.0 110.565 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 63.91 45.2 94.72 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.52 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 72.1 p -138.4 154.7 48.91 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.878 0.37 . . . . 0.0 110.549 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 87.8 mt -90.58 154.09 3.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.238 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.427 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 54.4 mt-10 -146.48 -179.26 6.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.395 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -52.83 -78.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.541 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -44.62 -54.03 6.56 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.62 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -50.25 -39.57 45.31 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.77 0.319 . . . . 0.0 110.668 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 76.1 t80 . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 120.914 0.388 . . . . 0.0 110.83 179.926 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 50.0 mt . . . . . 0 N--CA 1.456 -0.155 0 CA-C-O 120.845 0.355 . . . . 0.0 110.384 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.425 ' O ' ' N ' ' A' ' 8' ' ' GLN . 0.3 OUTLIER -95.43 125.5 40.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.43 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.467 ' O ' ' N ' ' A' ' 9' ' ' ILE . 80.4 tt0 -37.18 -72.21 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.149 0.5 . . . . 0.0 111.455 -179.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -47.13 -29.0 2.01 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.91 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.425 ' N ' ' O ' ' A' ' 5' ' ' SER . 45.4 tt0 -79.79 -24.72 41.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.518 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.467 ' N ' ' O ' ' A' ' 6' ' ' GLU . 3.2 tp -68.23 -36.27 74.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.8 t -76.33 -44.9 35.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.834 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -54.36 -50.23 67.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.731 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -66.34 -43.6 85.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.352 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -56.8 -42.68 79.93 Favored 'General case' 0 C--N 1.328 -0.37 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.427 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.3 tp10 -58.78 -45.97 88.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.419 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.99 -30.53 68.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.456 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -69.33 -49.25 57.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.768 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -65.23 -30.4 77.7 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 44.1 mt -72.57 -40.51 66.58 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.537 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -87.86 -14.93 38.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.439 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -113.81 101.81 9.64 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 179.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.512 ' C ' ' H ' ' A' ' 23' ' ' GLY . 55.8 mtpt -110.2 -31.35 7.36 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.859 0.362 . . . . 0.0 110.489 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.512 ' C ' ' H ' ' A' ' 24' ' ' ASP . 35.9 p30 -44.9 -15.58 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.565 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.512 ' H ' ' C ' ' A' ' 21' ' ' LYS . . . 68.96 -9.7 1.91 Allowed Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.512 ' H ' ' C ' ' A' ' 22' ' ' ASP . 42.0 p-10 -51.25 -11.95 0.12 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.847 0.356 . . . . 0.0 110.51 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.481 ' H ' ' C ' ' A' ' 23' ' ' GLY . . . 76.03 -70.56 2.05 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 55.9 m -69.65 169.75 12.15 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.125 0.488 . . . . 0.0 110.71 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.45 ' O ' ' O ' ' A' ' 63' ' ' ILE . 6.3 pt -138.25 165.54 25.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.304 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.457 ' H ' ' HG1' ' A' ' 28' ' ' THR . 0.2 OUTLIER -87.7 -170.4 2.99 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.073 179.954 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.3 t -79.79 -36.36 17.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.51 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -65.04 -50.34 66.58 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.628 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -42.12 -62.62 0.9 Allowed 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.51 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.99 -39.79 86.95 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.453 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -43.98 -68.25 0.21 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.011 0.434 . . . . 0.0 110.435 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.9 m -49.2 -51.38 33.28 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.781 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 91.7 t -50.6 -30.6 8.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.609 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -69.03 -34.58 64.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -68.79 -42.69 77.03 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.868 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.1 p -67.52 -39.75 85.07 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.73 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.462 ' O ' ' N ' ' A' ' 41' ' ' GLN . 51.4 mt -60.45 125.01 22.08 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.912 0.387 . . . . 0.0 110.129 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -65.07 66.27 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.801 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.483 ' C ' ' ND2' ' A' ' 42' ' ' ASN . 37.0 tt0 -140.0 172.88 12.13 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.241 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.49 ' N ' ' ND2' ' A' ' 42' ' ' ASN . 0.4 OUTLIER -142.76 67.37 18.52 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-O 120.871 0.367 . . . . 0.0 110.484 179.992 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -83.24 143.15 11.11 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.743 2.296 . . . . 0.0 111.956 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 22.9 p -64.28 130.71 44.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.269 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -71.35 -37.06 71.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.726 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -49.57 -42.32 44.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.341 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -58.38 -58.8 6.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.552 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.423 ' N ' ' CD1' ' A' ' 48' ' ' LEU . 9.6 mp -43.07 -46.04 5.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.599 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -57.92 -48.22 80.54 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.756 -0.377 . . . . 0.0 110.306 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -64.55 -50.81 65.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.071 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.557 ' O ' ' N ' ' A' ' 55' ' ' VAL . 87.1 mmm -63.08 -65.88 0.62 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.725 0.298 . . . . 0.0 111.153 -179.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 38.3 mm -43.54 -46.46 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.506 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.3 t -74.75 -20.56 59.77 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.606 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.496 ' N ' ' O ' ' A' ' 51' ' ' MET . 36.5 tt0 -106.38 7.89 31.37 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.787 0.327 . . . . 0.0 110.647 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.557 ' N ' ' O ' ' A' ' 51' ' ' MET . 71.8 t -123.82 -34.34 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 120.836 0.35 . . . . 0.0 110.495 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -55.6 85.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.595 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.473 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -72.03 -50.88 24.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.432 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.429 ' OD2' ' OE2' ' A' ' 64' ' ' GLU . 12.3 m-20 -45.74 -27.17 0.76 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.498 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.13 9.96 85.4 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.519 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 41.9 p30 -90.68 -0.83 57.82 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.807 0.337 . . . . 0.0 110.514 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 63.53 46.56 92.09 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.519 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 80.9 p -138.79 158.74 43.66 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.934 0.397 . . . . 0.0 110.338 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.45 ' O ' ' O ' ' A' ' 27' ' ' ILE . 87.4 mt -94.39 146.74 6.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.275 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.429 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 78.9 mt-10 -140.33 -179.85 6.23 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.326 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -53.24 -79.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.557 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -43.99 -53.43 6.24 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.499 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.415 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 96.6 mt-10 -49.43 -38.89 30.9 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.601 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 70.0 t80 . . . . . 0 C--N 1.326 -0.417 0 CA-C-O 120.923 0.392 . . . . 0.0 110.783 -179.967 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 19.1 mt . . . . . 0 CA--C 1.521 -0.142 0 CA-C-O 120.9 0.381 . . . . 0.0 110.325 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.412 ' O ' ' N ' ' A' ' 8' ' ' GLN . 0.3 OUTLIER -96.88 124.82 40.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.414 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.459 ' O ' ' N ' ' A' ' 9' ' ' ILE . 80.3 tt0 -37.67 -71.42 0.08 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.36 0.6 . . . . 0.0 111.535 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -46.64 -29.3 1.79 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.937 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.412 ' N ' ' O ' ' A' ' 5' ' ' SER . 45.4 tt0 -79.41 -25.67 42.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.579 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.459 ' N ' ' O ' ' A' ' 6' ' ' GLU . 3.1 tp -66.84 -36.38 77.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.1 t -76.79 -44.5 32.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.58 -178.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -53.45 -50.91 64.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.655 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -66.08 -44.46 84.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.337 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -55.45 -43.86 75.83 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.792 0.33 . . . . 0.0 110.431 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 -57.7 -45.12 86.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.443 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.09 -30.32 68.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.478 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -69.74 -50.78 40.1 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.738 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -62.9 -32.57 84.37 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 45.6 mt -69.78 -40.29 76.13 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.819 -0.353 . . . . 0.0 110.479 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -86.55 -13.26 46.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.426 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -116.45 102.08 9.2 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.527 ' C ' ' H ' ' A' ' 23' ' ' GLY . 55.5 mtpt -109.97 -32.38 7.06 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.853 0.359 . . . . 0.0 110.552 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.511 ' C ' ' H ' ' A' ' 24' ' ' ASP . 29.5 p30 -46.71 -13.53 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.553 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.527 ' H ' ' C ' ' A' ' 21' ' ' LYS . . . 66.21 -5.78 1.93 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.511 ' H ' ' C ' ' A' ' 22' ' ' ASP . 51.2 p-10 -54.16 -10.11 0.33 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.794 0.331 . . . . 0.0 110.558 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.451 ' H ' ' C ' ' A' ' 23' ' ' GLY . . . 75.79 -71.78 1.86 Allowed Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 88.4 m -67.91 168.64 11.31 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.35 0.595 . . . . 0.0 110.445 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.431 ' O ' ' O ' ' A' ' 63' ' ' ILE . 6.8 pt -136.78 164.9 29.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.379 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.594 ' CG2' ' H ' ' A' ' 29' ' ' VAL . 27.0 m -86.87 178.51 6.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.483 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.594 ' H ' ' CG2' ' A' ' 28' ' ' THR . 93.5 t -72.57 -43.8 61.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.357 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -61.31 -48.12 82.81 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.325 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -42.13 -62.54 0.91 Allowed 'General case' 0 C--O 1.236 0.393 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.2 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.52 -40.41 96.68 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.462 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -44.13 -67.67 0.26 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.234 0.54 . . . . 0.0 110.552 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.8 m -48.45 -51.41 27.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.686 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 86.0 t -51.21 -30.94 10.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.712 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -67.19 -34.02 66.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.804 179.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -69.91 -41.56 74.51 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.642 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.2 p -68.07 -39.55 82.93 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.592 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.49 ' O ' ' N ' ' A' ' 41' ' ' GLN . 55.4 mt -60.54 124.82 21.5 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.242 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -64.04 66.9 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.76 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.49 ' N ' ' O ' ' A' ' 39' ' ' LEU . 36.3 tt0 -141.59 173.38 11.55 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.304 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.491 ' N ' ' ND2' ' A' ' 42' ' ' ASN . 0.3 OUTLIER -143.64 67.59 16.22 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.543 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -82.81 143.86 12.0 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.772 2.315 . . . . 0.0 112.138 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 47.2 p -66.08 131.44 46.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.383 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -72.4 -35.33 68.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.676 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.91 -43.46 49.65 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.545 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -57.92 -58.72 7.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.581 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.426 ' N ' ' CD1' ' A' ' 48' ' ' LEU . 9.7 mp -44.3 -46.28 9.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.481 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -57.95 -46.66 84.74 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.515 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -64.56 -51.14 64.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.038 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.549 ' O ' ' N ' ' A' ' 55' ' ' VAL . 79.6 mmm -62.81 -64.15 1.0 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.053 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 32.1 mm -42.76 -47.96 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.654 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 37.8 t -72.16 -21.62 61.42 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.65 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.512 ' N ' ' O ' ' A' ' 51' ' ' MET . 51.1 tt0 -106.76 9.56 31.06 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.741 0.305 . . . . 0.0 110.536 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.549 ' N ' ' O ' ' A' ' 51' ' ' MET . 78.7 t -124.03 -38.95 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-O 120.777 0.322 . . . . 0.0 110.485 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -53.54 85.66 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.646 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -76.96 -45.86 26.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.478 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -51.06 -32.14 20.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.554 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 80.51 8.57 87.42 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.526 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 34.4 p-10 -87.31 -3.26 59.03 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.768 0.318 . . . . 0.0 110.561 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 64.35 47.12 87.79 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.526 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 79.3 p -142.76 153.45 43.3 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.881 0.372 . . . . 0.0 110.536 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.431 ' O ' ' O ' ' A' ' 27' ' ' ILE . 97.5 mt -88.51 155.61 3.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.207 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -145.86 -178.33 6.05 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.428 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -53.71 -76.61 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.382 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -46.19 -54.82 8.05 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.972 -0.291 . . . . 0.0 110.663 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -50.31 -40.62 49.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.903 0.383 . . . . 0.0 110.638 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 87.5 t80 . . . . . 0 C--N 1.329 -0.322 0 CA-C-O 121.058 0.456 . . . . 0.0 110.796 -179.967 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 52.5 mt . . . . . 0 N--CA 1.456 -0.14 0 CA-C-O 120.862 0.363 . . . . 0.0 110.228 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.443 ' O ' ' N ' ' A' ' 8' ' ' GLN . 0.2 OUTLIER -100.13 126.11 46.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.452 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.446 ' O ' ' N ' ' A' ' 9' ' ' ILE . 80.2 tt0 -36.73 -72.3 0.06 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.219 0.533 . . . . 0.0 111.485 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -46.78 -28.91 1.69 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.887 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.443 ' N ' ' O ' ' A' ' 5' ' ' SER . 44.4 tt0 -79.94 -26.32 40.14 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.608 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.446 ' N ' ' O ' ' A' ' 6' ' ' GLU . 3.2 tp -66.64 -35.64 75.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.0 t -77.48 -44.37 29.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.61 -179.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -54.06 -50.44 66.74 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.606 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -66.64 -44.35 82.18 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.397 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -56.12 -43.11 77.87 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.478 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.4 tp10 -59.28 -45.54 90.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.413 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.29 -32.71 73.05 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.426 179.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.414 ' O ' ' N ' ' A' ' 20' ' ' ASP . 33.9 t80 -68.61 -48.57 63.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.605 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -63.04 -32.22 83.38 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 45.8 mt -70.37 -39.23 74.71 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.575 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -88.66 -14.8 36.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.481 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 16' ' ' PHE . 29.7 t70 -115.57 102.17 9.54 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.594 -0.275 . . . . 0.0 110.315 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.511 ' C ' ' H ' ' A' ' 23' ' ' GLY . 55.1 mtpt -112.53 -30.06 7.26 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.833 0.349 . . . . 0.0 110.529 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.509 ' C ' ' H ' ' A' ' 24' ' ' ASP . 34.2 p30 -45.78 -15.14 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.55 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.511 ' H ' ' C ' ' A' ' 21' ' ' LYS . . . 66.7 -6.65 1.81 Allowed Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.509 ' H ' ' C ' ' A' ' 22' ' ' ASP . 50.0 p-10 -53.96 -10.68 0.35 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.836 0.351 . . . . 0.0 110.499 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.444 ' H ' ' C ' ' A' ' 23' ' ' GLY . . . 75.56 -71.88 1.79 Allowed Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 59.3 m -67.93 168.48 11.66 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.148 0.499 . . . . 0.0 110.485 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.425 ' O ' ' O ' ' A' ' 63' ' ' ILE . 3.7 pt -137.0 164.93 29.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.252 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.415 ' OG1' ' OE1' ' A' ' 31' ' ' GLU . 0.2 OUTLIER -88.76 -174.43 4.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.253 -179.854 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 86.5 t -78.44 -37.44 21.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.339 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -65.64 -50.88 63.37 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.594 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.415 ' OE1' ' OG1' ' A' ' 28' ' ' THR . 31.3 mt-10 -41.79 -61.34 1.13 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.409 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.06 -39.99 91.95 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.598 -179.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -43.74 -68.2 0.22 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.136 0.494 . . . . 0.0 110.623 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 16.2 m -48.62 -51.62 27.19 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.667 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 81.2 t -50.61 -31.44 9.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.728 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -67.65 -33.56 62.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.708 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -70.25 -42.14 72.59 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.643 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.0 p -67.47 -39.41 85.29 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.514 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.477 ' O ' ' N ' ' A' ' 41' ' ' GLN . 55.7 mt -61.06 123.4 17.55 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.99 0.424 . . . . 0.0 110.232 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -64.22 67.17 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.723 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.477 ' N ' ' O ' ' A' ' 39' ' ' LEU . 36.7 tt0 -140.73 173.24 11.68 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.259 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.473 ' ND2' ' C ' ' A' ' 41' ' ' GLN . 0.5 OUTLIER -143.61 67.8 16.4 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.418 179.919 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -82.99 143.72 11.67 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.831 2.354 . . . . 0.0 112.071 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 49.4 p -66.11 132.4 48.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.192 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -72.54 -33.92 67.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.638 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -52.15 -44.83 64.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.409 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -57.57 -59.83 4.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.624 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.7 mp -44.09 -45.99 8.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.408 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -58.05 -46.82 84.73 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.471 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -64.95 -50.99 64.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.089 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.555 ' O ' ' N ' ' A' ' 55' ' ' VAL . 80.5 mmm -62.95 -63.99 1.05 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.153 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 32.2 mm -42.79 -47.72 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.78 0.324 . . . . 0.0 110.719 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 37.3 t -72.29 -21.46 61.35 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.591 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.515 ' N ' ' O ' ' A' ' 51' ' ' MET . 53.0 tt0 -107.16 9.22 30.35 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.771 0.32 . . . . 0.0 110.626 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.555 ' N ' ' O ' ' A' ' 51' ' ' MET . 73.4 t -123.55 -37.68 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.338 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -54.71 85.49 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.922 0.391 . . . . 0.0 110.581 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.496 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -71.98 -49.97 32.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.52 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.419 ' OD2' ' OE2' ' A' ' 64' ' ' GLU . 10.9 m-20 -46.89 -28.8 1.71 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.436 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.97 9.74 86.57 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.522 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 44.4 p-10 -91.39 -0.44 57.64 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.83 0.348 . . . . 0.0 110.547 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 62.06 54.02 38.15 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.522 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 78.4 p -145.37 152.83 40.48 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.877 0.37 . . . . 0.0 110.452 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.425 ' O ' ' O ' ' A' ' 27' ' ' ILE . 97.1 mt -88.8 151.82 3.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.239 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.419 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 35.0 mt-10 -146.08 -178.49 6.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.46 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -53.3 -77.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.501 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -46.09 -54.04 9.24 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.585 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -50.24 -40.42 47.67 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.984 0.421 . . . . 0.0 110.659 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 86.5 t80 . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 120.989 0.423 . . . . 0.0 110.666 -179.984 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.514 ' CG ' ' H ' ' A' ' 3' ' ' ILE . 31.6 t70 -159.15 -178.38 7.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.288 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.514 ' H ' ' CG ' ' A' ' 2' ' ' ASP . 97.0 mt -134.93 150.91 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.268 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 48.2 mt -57.41 160.47 4.06 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.404 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.404 ' O ' ' N ' ' A' ' 8' ' ' GLN . 0.3 OUTLIER -92.99 125.91 37.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.449 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.467 ' O ' ' N ' ' A' ' 9' ' ' ILE . 80.7 tt0 -37.3 -72.47 0.06 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.281 0.562 . . . . 0.0 111.621 -179.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -47.51 -28.85 2.4 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.947 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.404 ' N ' ' O ' ' A' ' 5' ' ' SER . 44.9 tt0 -79.42 -24.65 42.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.399 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.467 ' N ' ' O ' ' A' ' 6' ' ' GLU . 3.4 tp -68.51 -36.92 76.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.3 t -75.23 -44.6 42.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.022 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -54.95 -50.24 69.39 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.642 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -66.52 -44.09 83.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.295 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -56.54 -42.74 78.99 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.404 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.9 tp10 -58.76 -46.09 88.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.367 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.92 -30.64 69.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.454 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -69.24 -48.95 60.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.853 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -65.82 -30.1 76.48 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 44.1 mt -72.74 -40.58 65.96 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.487 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -87.45 -15.2 38.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.481 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -113.82 101.82 9.64 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 110.213 -0.292 . . . . 0.0 110.213 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.512 ' C ' ' H ' ' A' ' 23' ' ' GLY . 55.2 mtpt -109.89 -31.68 7.32 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.011 0.434 . . . . 0.0 110.508 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.509 ' C ' ' H ' ' A' ' 24' ' ' ASP . 38.2 p30 -44.78 -15.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.554 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.512 ' H ' ' C ' ' A' ' 21' ' ' LYS . . . 69.18 -10.15 1.9 Allowed Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.509 ' H ' ' C ' ' A' ' 22' ' ' ASP . 35.6 p-10 -50.37 -11.61 0.08 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.743 0.306 . . . . 0.0 110.476 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.505 ' H ' ' C ' ' A' ' 23' ' ' GLY . . . 75.8 -70.51 2.0 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 60.4 m -70.08 169.82 12.68 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.078 0.466 . . . . 0.0 110.767 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.44 ' O ' ' O ' ' A' ' 63' ' ' ILE . 6.3 pt -138.24 165.0 26.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.362 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 49.8 p -86.45 -170.95 3.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.493 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 72.5 t -79.44 -36.81 18.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.5 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -64.57 -50.02 68.88 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.733 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -42.24 -62.1 1.02 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.588 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.65 -39.65 89.13 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.475 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -44.19 -67.98 0.24 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.11 0.481 . . . . 0.0 110.426 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 19.6 m -49.19 -51.4 33.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.749 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 89.7 t -50.79 -30.76 9.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.693 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -68.42 -35.72 71.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -67.64 -42.74 81.77 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.628 -0.429 . . . . 0.0 111.022 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.1 p -67.82 -39.2 83.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.784 0.326 . . . . 0.0 110.897 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.454 ' O ' ' N ' ' A' ' 41' ' ' GLN . 52.7 mt -61.26 125.45 23.8 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.994 0.426 . . . . 0.0 109.999 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -65.22 66.19 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.826 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.485 ' C ' ' ND2' ' A' ' 42' ' ' ASN . 37.3 tt0 -140.48 173.55 11.39 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.146 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.485 ' ND2' ' C ' ' A' ' 41' ' ' GLN . 0.4 OUTLIER -143.33 67.34 16.69 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.749 0.309 . . . . 0.0 110.346 -179.89 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -83.13 143.06 11.2 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.681 2.254 . . . . 0.0 111.995 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 31.5 p -64.47 130.59 44.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.374 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -71.81 -36.61 70.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.63 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -49.2 -41.98 38.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.332 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -58.59 -57.6 12.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.498 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.426 ' N ' ' CD1' ' A' ' 48' ' ' LEU . 9.6 mp -43.62 -46.42 7.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.546 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -57.56 -48.59 78.92 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.295 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -64.07 -50.76 67.09 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.183 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.531 ' O ' ' N ' ' A' ' 55' ' ' VAL . 65.6 mmm -63.45 -65.46 0.68 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.33 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 39.1 mm -44.79 -46.59 2.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.3 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.3 t -73.55 -20.34 60.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.594 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' A' ' 51' ' ' MET . 34.6 tt0 -106.59 8.83 31.43 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.785 0.326 . . . . 0.0 110.701 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.531 ' N ' ' O ' ' A' ' 51' ' ' MET . 75.0 t -124.09 -36.49 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 120.811 0.339 . . . . 0.0 110.442 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.4 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 32.4 t0 -54.35 86.15 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.628 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -73.89 -49.41 25.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.41 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.429 ' OD2' ' OE1' ' A' ' 64' ' ' GLU . 17.1 m-20 -48.94 -28.57 3.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.45 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.83 12.04 84.9 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.518 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 28.3 p30 -90.29 -0.77 57.78 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.783 0.325 . . . . 0.0 110.531 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.4 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 64.16 40.83 98.4 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.518 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 54.4 p -136.93 152.23 49.95 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.848 0.356 . . . . 0.0 110.406 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.44 ' O ' ' O ' ' A' ' 27' ' ' ILE . 82.3 mt -87.89 153.07 3.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.342 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.429 ' OE1' ' OD2' ' A' ' 58' ' ' ASP . 57.0 mt-10 -142.12 179.52 6.85 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.347 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -52.91 -79.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.475 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -44.46 -53.26 7.11 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.493 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -49.04 -38.0 22.5 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.719 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -73.44 -40.6 64.09 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.884 -0.327 . . . . 0.0 110.877 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 78.4 mt -65.98 -40.29 91.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.478 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 78.0 p -62.77 -42.56 99.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.522 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.3 tt -58.94 -39.84 82.85 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.67 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 80.4 mmm -72.01 -43.92 64.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.786 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -49.4 -45.59 46.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.779 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -80.89 -48.08 12.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.581 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -60.18 -56.25 23.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.577 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 42.9 t . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.489 179.897 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.506 ' CG ' ' H ' ' A' ' 3' ' ' ILE . 44.9 t0 -160.14 -178.64 7.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.307 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.506 ' H ' ' CG ' ' A' ' 2' ' ' ASP . 97.1 mt -135.47 150.12 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.355 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 46.6 mt -56.65 167.08 0.79 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.396 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.432 ' O ' ' N ' ' A' ' 8' ' ' GLN . 0.2 OUTLIER -99.8 126.7 45.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.36 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.443 ' O ' ' N ' ' A' ' 9' ' ' ILE . 80.2 tt0 -36.69 -72.11 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.138 0.494 . . . . 0.0 111.571 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -47.71 -28.54 2.5 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.929 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.432 ' N ' ' O ' ' A' ' 5' ' ' SER . 44.0 tt0 -79.76 -25.99 40.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.475 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.443 ' N ' ' O ' ' A' ' 6' ' ' GLU . 3.2 tp -67.25 -36.27 76.27 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 61.7 t -76.02 -44.36 37.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.913 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -55.2 -49.87 70.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.743 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -66.93 -43.97 81.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.365 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -57.04 -42.72 80.98 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.815 0.34 . . . . 0.0 110.366 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.1 tp10 -58.96 -45.13 91.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.377 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.8 -31.6 70.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.43 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.421 ' O ' ' N ' ' A' ' 20' ' ' ASP . 28.9 t80 -69.01 -49.76 54.85 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.814 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -63.66 -31.58 81.25 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 46.5 mt -71.8 -40.03 69.47 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.48 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -87.29 -15.83 36.9 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.513 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.421 ' N ' ' O ' ' A' ' 16' ' ' PHE . 30.2 t70 -114.06 102.19 9.94 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 179.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.508 ' C ' ' H ' ' A' ' 23' ' ' GLY . 55.5 mtpt -110.45 -31.23 7.34 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.942 0.401 . . . . 0.0 110.547 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.503 ' C ' ' H ' ' A' ' 24' ' ' ASP . 35.8 p30 -45.19 -15.61 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.575 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.508 ' H ' ' C ' ' A' ' 21' ' ' LYS . . . 68.47 -8.96 1.92 Allowed Glycine 0 CA--C 1.523 0.54 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.503 ' H ' ' C ' ' A' ' 22' ' ' ASP . 43.6 p-10 -51.93 -11.6 0.17 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.86 0.362 . . . . 0.0 110.545 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.473 ' H ' ' C ' ' A' ' 23' ' ' GLY . . . 75.34 -70.49 1.88 Allowed Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 57.3 m -69.29 169.19 12.69 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.177 0.513 . . . . 0.0 110.579 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.7 pt -138.43 165.06 25.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.18 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.491 ' H ' ' HG1' ' A' ' 28' ' ' THR . 0.2 OUTLIER -87.28 -171.23 3.38 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.117 179.946 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.1 t -79.08 -37.25 19.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.458 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.0 -50.22 69.36 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.669 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -42.25 -62.27 0.99 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.542 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.56 -39.54 88.34 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.47 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -44.52 -68.05 0.23 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.146 0.498 . . . . 0.0 110.317 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.6 m -48.62 -51.65 27.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.808 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 86.2 t -50.62 -31.87 9.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.694 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -67.2 -35.58 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -68.03 -42.61 80.33 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.951 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.0 p -68.01 -38.68 82.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.87 0.367 . . . . 0.0 110.818 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.456 ' O ' ' N ' ' A' ' 41' ' ' GLN . 55.9 mt -61.41 124.15 19.82 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.912 0.386 . . . . 0.0 110.099 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -64.93 66.83 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.754 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.623 ' NE2' ' NZ ' ' A' ' 75' ' ' LYS . 37.2 tt0 -141.0 173.75 11.17 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.122 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.487 ' ND2' ' C ' ' A' ' 41' ' ' GLN . 0.4 OUTLIER -143.43 67.41 16.54 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.823 0.344 . . . . 0.0 110.419 -179.925 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -83.09 143.38 11.4 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.769 2.313 . . . . 0.0 112.096 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 40.6 p -65.87 132.41 48.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.345 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -72.16 -34.49 68.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.642 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -51.33 -44.55 62.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.453 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -57.28 -59.86 4.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.569 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.413 ' N ' ' CD1' ' A' ' 48' ' ' LEU . 9.6 mp -44.33 -46.06 9.08 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.467 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -57.9 -47.41 82.87 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.424 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -64.14 -50.77 66.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.158 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.554 ' O ' ' N ' ' A' ' 55' ' ' VAL . 77.2 mmm -63.67 -63.63 1.12 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.333 -179.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 31.3 mm -43.37 -47.42 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.336 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.8 t -71.92 -21.8 61.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.691 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.501 ' N ' ' O ' ' A' ' 51' ' ' MET . 53.2 tt0 -107.21 9.19 30.25 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 120.823 0.344 . . . . 0.0 110.578 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.554 ' N ' ' O ' ' A' ' 51' ' ' MET . 73.2 t -123.09 -38.38 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-O 120.839 0.352 . . . . 0.0 110.385 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -55.02 85.55 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.481 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -72.05 -50.05 31.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.447 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.427 ' OD2' ' OE2' ' A' ' 64' ' ' GLU . 17.4 m-20 -47.05 -28.59 1.76 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.412 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.83 10.33 86.12 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.934 -0.867 . . . . 0.0 110.934 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.52 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 36.3 p-10 -89.49 -1.87 58.18 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.773 0.32 . . . . 0.0 110.565 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 63.91 45.2 94.72 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.52 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 72.1 p -138.4 154.7 48.91 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.878 0.37 . . . . 0.0 110.549 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 87.8 mt -90.58 154.09 3.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.238 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.427 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 54.4 mt-10 -146.48 -179.26 6.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.395 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -52.83 -78.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.541 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -44.62 -54.03 6.56 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.62 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.429 ' O ' ' OG ' ' A' ' 70' ' ' SER . 98.2 mt-10 -50.25 -39.57 45.31 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.77 0.319 . . . . 0.0 110.668 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -71.04 -43.06 68.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.914 0.388 . . . . 0.0 110.83 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.0 mt -62.8 -37.02 85.05 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.31 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 67' ' ' GLU . 78.0 p -63.14 -43.15 99.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.48 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.42 ' H ' ' HG ' ' A' ' 70' ' ' SER . 6.0 tt -57.34 -40.82 78.79 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.614 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.428 ' O ' ' N ' ' A' ' 76' ' ' VAL . 80.8 mmm -70.74 -41.9 71.21 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.628 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -47.83 -44.56 29.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.567 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.1 mtpt -80.49 -50.31 10.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.615 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.623 ' NZ ' ' NE2' ' A' ' 41' ' ' GLN . 87.1 tttt -58.58 -56.82 17.2 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.502 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.428 ' N ' ' O ' ' A' ' 72' ' ' MET . 46.6 t . . . . . 0 C--O 1.221 -0.43 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.535 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.508 ' CG ' ' H ' ' A' ' 3' ' ' ILE . 44.7 t0 -160.14 -179.77 8.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.395 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.508 ' H ' ' CG ' ' A' ' 2' ' ' ASP . 97.1 mt -134.94 151.64 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-O 120.95 0.405 . . . . 0.0 110.363 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 50.0 mt -57.33 163.19 2.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.384 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.425 ' O ' ' N ' ' A' ' 8' ' ' GLN . 0.3 OUTLIER -95.43 125.5 40.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.43 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.467 ' O ' ' N ' ' A' ' 9' ' ' ILE . 80.4 tt0 -37.18 -72.21 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.149 0.5 . . . . 0.0 111.455 -179.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -47.13 -29.0 2.01 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.91 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.425 ' N ' ' O ' ' A' ' 5' ' ' SER . 45.4 tt0 -79.79 -24.72 41.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.518 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.467 ' N ' ' O ' ' A' ' 6' ' ' GLU . 3.2 tp -68.23 -36.27 74.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.8 t -76.33 -44.9 35.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.834 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -54.36 -50.23 67.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.731 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -66.34 -43.6 85.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.352 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -56.8 -42.68 79.93 Favored 'General case' 0 C--N 1.328 -0.37 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.427 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.3 tp10 -58.78 -45.97 88.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.419 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.99 -30.53 68.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.456 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -69.33 -49.25 57.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.768 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -65.23 -30.4 77.7 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 44.1 mt -72.57 -40.51 66.58 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.537 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -87.86 -14.93 38.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.439 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -113.81 101.81 9.64 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 179.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.512 ' C ' ' H ' ' A' ' 23' ' ' GLY . 55.8 mtpt -110.2 -31.35 7.36 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.859 0.362 . . . . 0.0 110.489 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.512 ' C ' ' H ' ' A' ' 24' ' ' ASP . 35.9 p30 -44.9 -15.58 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.565 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.512 ' H ' ' C ' ' A' ' 21' ' ' LYS . . . 68.96 -9.7 1.91 Allowed Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.512 ' H ' ' C ' ' A' ' 22' ' ' ASP . 42.0 p-10 -51.25 -11.95 0.12 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.847 0.356 . . . . 0.0 110.51 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.481 ' H ' ' C ' ' A' ' 23' ' ' GLY . . . 76.03 -70.56 2.05 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 55.9 m -69.65 169.75 12.15 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.125 0.488 . . . . 0.0 110.71 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.45 ' O ' ' O ' ' A' ' 63' ' ' ILE . 6.3 pt -138.25 165.54 25.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.304 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.457 ' H ' ' HG1' ' A' ' 28' ' ' THR . 0.2 OUTLIER -87.7 -170.4 2.99 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.073 179.954 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.3 t -79.79 -36.36 17.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.51 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -65.04 -50.34 66.58 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.628 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -42.12 -62.62 0.9 Allowed 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.51 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.99 -39.79 86.95 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.453 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -43.98 -68.25 0.21 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.011 0.434 . . . . 0.0 110.435 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.9 m -49.2 -51.38 33.28 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.781 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 91.7 t -50.6 -30.6 8.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.609 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -69.03 -34.58 64.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -68.79 -42.69 77.03 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.868 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.1 p -67.52 -39.75 85.07 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.73 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.462 ' O ' ' N ' ' A' ' 41' ' ' GLN . 51.4 mt -60.45 125.01 22.08 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.912 0.387 . . . . 0.0 110.129 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -65.07 66.27 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.801 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.483 ' C ' ' ND2' ' A' ' 42' ' ' ASN . 37.0 tt0 -140.0 172.88 12.13 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.241 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.49 ' N ' ' ND2' ' A' ' 42' ' ' ASN . 0.4 OUTLIER -142.76 67.37 18.52 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-O 120.871 0.367 . . . . 0.0 110.484 179.992 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -83.24 143.15 11.11 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.743 2.296 . . . . 0.0 111.956 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 22.9 p -64.28 130.71 44.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.269 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -71.35 -37.06 71.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.726 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -49.57 -42.32 44.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.341 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -58.38 -58.8 6.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.552 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.423 ' N ' ' CD1' ' A' ' 48' ' ' LEU . 9.6 mp -43.07 -46.04 5.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.599 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -57.92 -48.22 80.54 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.756 -0.377 . . . . 0.0 110.306 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -64.55 -50.81 65.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.071 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.557 ' O ' ' N ' ' A' ' 55' ' ' VAL . 87.1 mmm -63.08 -65.88 0.62 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.725 0.298 . . . . 0.0 111.153 -179.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 38.3 mm -43.54 -46.46 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.506 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.3 t -74.75 -20.56 59.77 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.606 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.496 ' N ' ' O ' ' A' ' 51' ' ' MET . 36.5 tt0 -106.38 7.89 31.37 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.787 0.327 . . . . 0.0 110.647 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.557 ' N ' ' O ' ' A' ' 51' ' ' MET . 71.8 t -123.82 -34.34 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 120.836 0.35 . . . . 0.0 110.495 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -55.6 85.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.595 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.473 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -72.03 -50.88 24.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.432 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.429 ' OD2' ' OE2' ' A' ' 64' ' ' GLU . 12.3 m-20 -45.74 -27.17 0.76 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.498 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.13 9.96 85.4 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.519 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 41.9 p30 -90.68 -0.83 57.82 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.807 0.337 . . . . 0.0 110.514 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 63.53 46.56 92.09 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.519 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 80.9 p -138.79 158.74 43.66 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.934 0.397 . . . . 0.0 110.338 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.45 ' O ' ' O ' ' A' ' 27' ' ' ILE . 87.4 mt -94.39 146.74 6.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.275 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.429 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 78.9 mt-10 -140.33 -179.85 6.23 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.326 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -53.24 -79.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.557 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -43.99 -53.43 6.24 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.499 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.415 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 96.6 mt-10 -49.43 -38.89 30.9 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.601 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -72.71 -41.07 65.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.923 0.392 . . . . 0.0 110.783 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 80.6 mt -65.81 -40.02 91.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.458 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 77.7 p -62.17 -42.76 99.58 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.098 0.475 . . . . 0.0 110.473 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.3 tt -59.26 -39.6 83.36 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.721 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.4 ' O ' ' N ' ' A' ' 76' ' ' VAL . 79.9 mmm -72.44 -44.74 61.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.778 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -49.06 -46.28 44.2 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.884 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -80.7 -49.13 11.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.695 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -58.27 -55.45 34.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.678 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.4 ' N ' ' O ' ' A' ' 72' ' ' MET . 43.7 t . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.473 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.511 ' CG ' ' H ' ' A' ' 3' ' ' ILE . 29.1 t70 -160.03 -177.25 6.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.281 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.511 ' H ' ' CG ' ' A' ' 2' ' ' ASP . 97.4 mt -135.35 149.62 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.407 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 19.1 mt -57.69 165.41 1.68 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.325 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.412 ' O ' ' N ' ' A' ' 8' ' ' GLN . 0.3 OUTLIER -96.88 124.82 40.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.414 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.459 ' O ' ' N ' ' A' ' 9' ' ' ILE . 80.3 tt0 -37.67 -71.42 0.08 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.36 0.6 . . . . 0.0 111.535 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -46.64 -29.3 1.79 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.937 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.412 ' N ' ' O ' ' A' ' 5' ' ' SER . 45.4 tt0 -79.41 -25.67 42.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.579 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.459 ' N ' ' O ' ' A' ' 6' ' ' GLU . 3.1 tp -66.84 -36.38 77.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.1 t -76.79 -44.5 32.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.58 -178.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -53.45 -50.91 64.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.655 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -66.08 -44.46 84.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.337 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -55.45 -43.86 75.83 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.792 0.33 . . . . 0.0 110.431 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 -57.7 -45.12 86.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.443 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.09 -30.32 68.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.478 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -69.74 -50.78 40.1 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.738 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -62.9 -32.57 84.37 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 45.6 mt -69.78 -40.29 76.13 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.819 -0.353 . . . . 0.0 110.479 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -86.55 -13.26 46.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.426 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -116.45 102.08 9.2 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.527 ' C ' ' H ' ' A' ' 23' ' ' GLY . 55.5 mtpt -109.97 -32.38 7.06 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.853 0.359 . . . . 0.0 110.552 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.511 ' C ' ' H ' ' A' ' 24' ' ' ASP . 29.5 p30 -46.71 -13.53 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.553 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.527 ' H ' ' C ' ' A' ' 21' ' ' LYS . . . 66.21 -5.78 1.93 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.511 ' H ' ' C ' ' A' ' 22' ' ' ASP . 51.2 p-10 -54.16 -10.11 0.33 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.794 0.331 . . . . 0.0 110.558 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.451 ' H ' ' C ' ' A' ' 23' ' ' GLY . . . 75.79 -71.78 1.86 Allowed Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 88.4 m -67.91 168.64 11.31 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.35 0.595 . . . . 0.0 110.445 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.431 ' O ' ' O ' ' A' ' 63' ' ' ILE . 6.8 pt -136.78 164.9 29.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.379 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.594 ' CG2' ' H ' ' A' ' 29' ' ' VAL . 27.0 m -86.87 178.51 6.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.483 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.594 ' H ' ' CG2' ' A' ' 28' ' ' THR . 93.5 t -72.57 -43.8 61.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.357 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -61.31 -48.12 82.81 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.325 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -42.13 -62.54 0.91 Allowed 'General case' 0 C--O 1.236 0.393 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.2 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.52 -40.41 96.68 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.462 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -44.13 -67.67 0.26 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.234 0.54 . . . . 0.0 110.552 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.8 m -48.45 -51.41 27.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.686 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 86.0 t -51.21 -30.94 10.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.712 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -67.19 -34.02 66.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.804 179.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -69.91 -41.56 74.51 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.642 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.2 p -68.07 -39.55 82.93 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.592 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.49 ' O ' ' N ' ' A' ' 41' ' ' GLN . 55.4 mt -60.54 124.82 21.5 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.242 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -64.04 66.9 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.76 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.616 ' NE2' ' NZ ' ' A' ' 75' ' ' LYS . 36.3 tt0 -141.59 173.38 11.55 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.304 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.491 ' N ' ' ND2' ' A' ' 42' ' ' ASN . 0.3 OUTLIER -143.64 67.59 16.22 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.543 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -82.81 143.86 12.0 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.772 2.315 . . . . 0.0 112.138 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 47.2 p -66.08 131.44 46.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.383 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -72.4 -35.33 68.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.676 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.91 -43.46 49.65 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.545 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -57.92 -58.72 7.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.581 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.426 ' N ' ' CD1' ' A' ' 48' ' ' LEU . 9.7 mp -44.3 -46.28 9.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.481 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -57.95 -46.66 84.74 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.515 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -64.56 -51.14 64.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.038 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.549 ' O ' ' N ' ' A' ' 55' ' ' VAL . 79.6 mmm -62.81 -64.15 1.0 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.053 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 32.1 mm -42.76 -47.96 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.654 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 37.8 t -72.16 -21.62 61.42 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.65 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.512 ' N ' ' O ' ' A' ' 51' ' ' MET . 51.1 tt0 -106.76 9.56 31.06 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.741 0.305 . . . . 0.0 110.536 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.549 ' N ' ' O ' ' A' ' 51' ' ' MET . 78.7 t -124.03 -38.95 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-O 120.777 0.322 . . . . 0.0 110.485 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -53.54 85.66 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.646 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -76.96 -45.86 26.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.478 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -51.06 -32.14 20.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.554 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 80.51 8.57 87.42 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.526 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 34.4 p-10 -87.31 -3.26 59.03 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.768 0.318 . . . . 0.0 110.561 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 64.35 47.12 87.79 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.526 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 79.3 p -142.76 153.45 43.3 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.881 0.372 . . . . 0.0 110.536 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.431 ' O ' ' O ' ' A' ' 27' ' ' ILE . 97.5 mt -88.51 155.61 3.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.207 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -145.86 -178.33 6.05 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.428 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -53.71 -76.61 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.382 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -46.19 -54.82 8.05 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.972 -0.291 . . . . 0.0 110.663 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.44 ' O ' ' OG ' ' A' ' 70' ' ' SER . 93.8 mt-10 -50.31 -40.62 49.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.903 0.383 . . . . 0.0 110.638 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -70.76 -43.47 68.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.058 0.456 . . . . 0.0 110.796 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 46.7 mt -63.01 -37.21 86.27 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.322 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' A' ' 67' ' ' GLU . 77.7 p -62.44 -43.03 99.81 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.237 0.541 . . . . 0.0 110.37 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.412 ' H ' ' HG ' ' A' ' 70' ' ' SER . 5.6 tt -57.43 -39.86 77.14 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.643 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.43 ' O ' ' N ' ' A' ' 76' ' ' VAL . 81.0 mmm -71.15 -41.16 70.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.616 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -48.91 -44.08 39.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.539 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 31.0 mtpt -80.42 -50.39 10.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.625 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.616 ' NZ ' ' NE2' ' A' ' 41' ' ' GLN . 87.0 tttt -58.06 -56.49 21.31 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.471 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.43 ' N ' ' O ' ' A' ' 72' ' ' MET . 47.9 t . . . . . 0 C--O 1.221 -0.438 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.677 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.496 ' CG ' ' H ' ' A' ' 3' ' ' ILE . 44.8 t0 -158.61 -178.94 7.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.272 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.496 ' H ' ' CG ' ' A' ' 2' ' ' ASP . 97.2 mt -135.36 149.25 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.416 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 52.5 mt -55.83 167.64 0.55 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.228 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.443 ' O ' ' N ' ' A' ' 8' ' ' GLN . 0.2 OUTLIER -100.13 126.11 46.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.452 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.446 ' O ' ' N ' ' A' ' 9' ' ' ILE . 80.2 tt0 -36.73 -72.3 0.06 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.219 0.533 . . . . 0.0 111.485 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -46.78 -28.91 1.69 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.887 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.443 ' N ' ' O ' ' A' ' 5' ' ' SER . 44.4 tt0 -79.94 -26.32 40.14 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.608 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.446 ' N ' ' O ' ' A' ' 6' ' ' GLU . 3.2 tp -66.64 -35.64 75.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.0 t -77.48 -44.37 29.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.61 -179.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -54.06 -50.44 66.74 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.606 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -66.64 -44.35 82.18 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.397 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -56.12 -43.11 77.87 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.478 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.4 tp10 -59.28 -45.54 90.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.413 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.29 -32.71 73.05 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.426 179.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.414 ' O ' ' N ' ' A' ' 20' ' ' ASP . 33.9 t80 -68.61 -48.57 63.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.605 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -63.04 -32.22 83.38 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 45.8 mt -70.37 -39.23 74.71 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.575 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -88.66 -14.8 36.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.481 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 16' ' ' PHE . 29.7 t70 -115.57 102.17 9.54 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.594 -0.275 . . . . 0.0 110.315 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.511 ' C ' ' H ' ' A' ' 23' ' ' GLY . 55.1 mtpt -112.53 -30.06 7.26 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.833 0.349 . . . . 0.0 110.529 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.509 ' C ' ' H ' ' A' ' 24' ' ' ASP . 34.2 p30 -45.78 -15.14 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.55 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.511 ' H ' ' C ' ' A' ' 21' ' ' LYS . . . 66.7 -6.65 1.81 Allowed Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.509 ' H ' ' C ' ' A' ' 22' ' ' ASP . 50.0 p-10 -53.96 -10.68 0.35 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.836 0.351 . . . . 0.0 110.499 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.444 ' H ' ' C ' ' A' ' 23' ' ' GLY . . . 75.56 -71.88 1.79 Allowed Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 59.3 m -67.93 168.48 11.66 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.148 0.499 . . . . 0.0 110.485 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.425 ' O ' ' O ' ' A' ' 63' ' ' ILE . 3.7 pt -137.0 164.93 29.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.252 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.415 ' OG1' ' OE1' ' A' ' 31' ' ' GLU . 0.2 OUTLIER -88.76 -174.43 4.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.253 -179.854 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 86.5 t -78.44 -37.44 21.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.339 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -65.64 -50.88 63.37 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.594 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.415 ' OE1' ' OG1' ' A' ' 28' ' ' THR . 31.3 mt-10 -41.79 -61.34 1.13 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.409 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.06 -39.99 91.95 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.598 -179.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -43.74 -68.2 0.22 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.136 0.494 . . . . 0.0 110.623 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 16.2 m -48.62 -51.62 27.19 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.667 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 81.2 t -50.61 -31.44 9.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.728 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -67.65 -33.56 62.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.708 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -70.25 -42.14 72.59 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.643 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.0 p -67.47 -39.41 85.29 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.514 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.477 ' O ' ' N ' ' A' ' 41' ' ' GLN . 55.7 mt -61.06 123.4 17.55 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.99 0.424 . . . . 0.0 110.232 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -64.22 67.17 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.723 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.625 ' NE2' ' NZ ' ' A' ' 75' ' ' LYS . 36.7 tt0 -140.73 173.24 11.68 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.259 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.473 ' ND2' ' C ' ' A' ' 41' ' ' GLN . 0.5 OUTLIER -143.61 67.8 16.4 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.418 179.919 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -82.99 143.72 11.67 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.831 2.354 . . . . 0.0 112.071 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 49.4 p -66.11 132.4 48.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.192 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -72.54 -33.92 67.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.638 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -52.15 -44.83 64.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.409 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -57.57 -59.83 4.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.624 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.7 mp -44.09 -45.99 8.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.408 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -58.05 -46.82 84.73 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.471 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -64.95 -50.99 64.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.089 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.555 ' O ' ' N ' ' A' ' 55' ' ' VAL . 80.5 mmm -62.95 -63.99 1.05 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.153 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 32.2 mm -42.79 -47.72 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.78 0.324 . . . . 0.0 110.719 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 37.3 t -72.29 -21.46 61.35 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.591 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.515 ' N ' ' O ' ' A' ' 51' ' ' MET . 53.0 tt0 -107.16 9.22 30.35 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.771 0.32 . . . . 0.0 110.626 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.555 ' N ' ' O ' ' A' ' 51' ' ' MET . 73.4 t -123.55 -37.68 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.338 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -54.71 85.49 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.922 0.391 . . . . 0.0 110.581 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.496 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -71.98 -49.97 32.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.52 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.419 ' OD2' ' OE2' ' A' ' 64' ' ' GLU . 10.9 m-20 -46.89 -28.8 1.71 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.436 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.97 9.74 86.57 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.522 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 44.4 p-10 -91.39 -0.44 57.64 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.83 0.348 . . . . 0.0 110.547 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 62.06 54.02 38.15 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.522 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 78.4 p -145.37 152.83 40.48 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.877 0.37 . . . . 0.0 110.452 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.425 ' O ' ' O ' ' A' ' 27' ' ' ILE . 97.1 mt -88.8 151.82 3.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.239 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.419 ' OE2' ' OD2' ' A' ' 58' ' ' ASP . 35.0 mt-10 -146.08 -178.49 6.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.46 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -53.3 -77.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.501 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -46.09 -54.04 9.24 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.585 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.431 ' O ' ' OG ' ' A' ' 70' ' ' SER . 95.0 mt-10 -50.24 -40.42 47.67 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.984 0.421 . . . . 0.0 110.659 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -70.66 -43.13 69.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.989 0.423 . . . . 0.0 110.666 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 90.3 mt -62.45 -37.53 86.26 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.321 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' A' ' 67' ' ' GLU . 77.8 p -62.71 -43.02 99.89 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.164 0.507 . . . . 0.0 110.464 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.7 tt -57.14 -40.67 77.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.618 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.426 ' O ' ' N ' ' A' ' 76' ' ' VAL . 79.3 mmm -70.87 -41.27 71.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.545 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -47.93 -44.74 30.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.628 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 29.7 mtpt -80.95 -50.46 9.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.652 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.625 ' NZ ' ' NE2' ' A' ' 41' ' ' GLN . 86.5 tttt -57.87 -56.38 22.7 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.468 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.426 ' N ' ' O ' ' A' ' 72' ' ' MET . 46.3 t . . . . . 0 C--O 1.221 -0.438 0 CA-C-O 117.906 -1.045 . . . . 0.0 110.526 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 48.2 mt . . . . . 0 N--CA 1.455 -0.181 0 CA-C-O 120.938 0.399 . . . . 0.0 110.404 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.404 ' O ' ' N ' ' A' ' 8' ' ' GLN . 0.3 OUTLIER -92.99 125.91 37.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.449 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.467 ' O ' ' N ' ' A' ' 9' ' ' ILE . 80.7 tt0 -37.3 -72.47 0.06 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.281 0.562 . . . . 0.0 111.621 -179.219 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -47.51 -28.85 2.4 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.947 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.404 ' N ' ' O ' ' A' ' 5' ' ' SER . 44.9 tt0 -79.42 -24.65 42.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.399 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.467 ' N ' ' O ' ' A' ' 6' ' ' GLU . 3.4 tp -68.51 -36.92 76.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.3 t -75.23 -44.6 42.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.022 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -54.95 -50.24 69.39 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.642 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -66.52 -44.09 83.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.295 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -56.54 -42.74 78.99 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.404 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.9 tp10 -58.76 -46.09 88.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.367 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.92 -30.64 69.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.454 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -69.24 -48.95 60.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.853 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -65.82 -30.1 76.48 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 44.1 mt -72.74 -40.58 65.96 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.487 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -87.45 -15.2 38.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.481 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -113.82 101.82 9.64 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 110.213 -0.292 . . . . 0.0 110.213 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.505 ' O ' ' N ' ' A' ' 23' ' ' GLY . 55.2 mtpt -109.89 -31.68 7.32 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.011 0.434 . . . . 0.0 110.508 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.469 ' C ' ' H ' ' A' ' 24' ' ' ASP . 38.2 p30 -44.78 -15.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.554 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 21' ' ' LYS . . . 69.18 -10.15 1.9 Allowed Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.469 ' H ' ' C ' ' A' ' 22' ' ' ASP . 35.6 p-10 -50.37 -11.61 0.08 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.743 0.306 . . . . 0.0 110.476 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.469 ' H ' ' C ' ' A' ' 23' ' ' GLY . . . 75.8 -70.51 2.0 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 60.4 m -70.08 169.82 12.68 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.078 0.466 . . . . 0.0 110.767 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.44 ' O ' ' O ' ' A' ' 63' ' ' ILE . 6.3 pt -138.24 165.0 26.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.362 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 49.8 p -86.45 -170.95 3.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.493 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 72.5 t -79.44 -36.81 18.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.5 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.485 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 96.5 mt-10 -64.57 -50.02 68.88 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.733 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -42.24 -62.1 1.02 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.588 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.576 ' O ' HD13 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -60.65 -39.65 89.13 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.475 -179.647 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' A' ' 30' ' ' GLU . . . -44.19 -67.98 0.24 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.11 0.481 . . . . 0.0 110.426 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 19.6 m -49.19 -51.4 33.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.749 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 89.7 t -50.79 -30.76 9.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.693 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.524 HD13 HD12 ' A' ' 32' ' ' LEU . 1.0 OUTLIER -68.42 -35.72 71.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.476 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -67.64 -42.74 81.77 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.628 -0.429 . . . . 0.0 111.022 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.1 p -67.82 -39.2 83.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.784 0.326 . . . . 0.0 110.897 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.454 ' O ' ' N ' ' A' ' 41' ' ' GLN . 52.7 mt -61.26 125.45 23.8 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.994 0.426 . . . . 0.0 109.999 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -65.22 66.19 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.826 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.454 ' N ' ' O ' ' A' ' 39' ' ' LEU . 37.3 tt0 -140.48 173.55 11.39 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.146 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.4 ' H ' ' HG2' ' A' ' 41' ' ' GLN . 2.6 m120 -143.33 67.34 16.69 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.749 0.309 . . . . 0.0 110.346 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -83.13 143.06 11.2 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.681 2.254 . . . . 0.0 111.995 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 31.5 p -64.47 130.59 44.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.374 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -71.81 -36.61 70.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.63 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -49.2 -41.98 38.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.332 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -58.59 -57.6 12.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.498 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.486 ' N ' HD12 ' A' ' 48' ' ' LEU . 9.6 mp -43.62 -46.42 7.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.546 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -57.56 -48.59 78.92 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.295 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -64.07 -50.76 67.09 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.183 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.531 ' O ' ' N ' ' A' ' 55' ' ' VAL . 65.6 mmm -63.45 -65.46 0.68 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.33 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 39.1 mm -44.79 -46.59 2.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.3 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.3 t -73.55 -20.34 60.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.594 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' A' ' 51' ' ' MET . 34.6 tt0 -106.59 8.83 31.43 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.785 0.326 . . . . 0.0 110.701 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.531 ' N ' ' O ' ' A' ' 51' ' ' MET . 75.0 t -124.09 -36.49 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 120.811 0.339 . . . . 0.0 110.442 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.4 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 32.4 t0 -54.35 86.15 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.628 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -73.89 -49.41 25.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.41 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.429 ' OD2' ' OE1' ' A' ' 64' ' ' GLU . 17.1 m-20 -48.94 -28.57 3.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.45 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.83 12.04 84.9 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.518 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 28.3 p30 -90.29 -0.77 57.78 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.783 0.325 . . . . 0.0 110.531 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.4 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 64.16 40.83 98.4 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.518 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 54.4 p -136.93 152.23 49.95 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.848 0.356 . . . . 0.0 110.406 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.44 ' O ' ' O ' ' A' ' 27' ' ' ILE . 82.3 mt -87.89 153.07 3.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.342 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.443 ' H ' ' HB2' ' A' ' 67' ' ' GLU . 57.0 mt-10 -142.12 179.52 6.85 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.347 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -52.91 -79.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.475 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -44.46 -53.26 7.11 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.493 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.443 ' HB2' ' H ' ' A' ' 64' ' ' GLU . 95.7 mt-10 -49.04 -38.0 22.5 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.719 179.413 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 65.4 t80 . . . . . 0 C--N 1.327 -0.379 0 C-N-CA 120.884 -0.327 . . . . 0.0 110.877 179.911 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 46.6 mt . . . . . 0 N--CA 1.454 -0.26 0 CA-C-O 120.875 0.369 . . . . 0.0 110.396 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.432 ' O ' ' N ' ' A' ' 8' ' ' GLN . 0.2 OUTLIER -99.8 126.7 45.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.36 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.443 ' O ' ' N ' ' A' ' 9' ' ' ILE . 80.2 tt0 -36.69 -72.11 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.138 0.494 . . . . 0.0 111.571 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -47.71 -28.54 2.5 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.929 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.432 ' N ' ' O ' ' A' ' 5' ' ' SER . 44.0 tt0 -79.76 -25.99 40.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.475 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.443 ' N ' ' O ' ' A' ' 6' ' ' GLU . 3.2 tp -67.25 -36.27 76.27 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 61.7 t -76.02 -44.36 37.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.913 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -55.2 -49.87 70.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.743 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -66.93 -43.97 81.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.365 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -57.04 -42.72 80.98 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.815 0.34 . . . . 0.0 110.366 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.1 tp10 -58.96 -45.13 91.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.377 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.8 -31.6 70.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.43 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.421 ' O ' ' N ' ' A' ' 20' ' ' ASP . 28.9 t80 -69.01 -49.76 54.85 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.814 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -63.66 -31.58 81.25 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 46.5 mt -71.8 -40.03 69.47 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.48 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -87.29 -15.83 36.9 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.513 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.421 ' N ' ' O ' ' A' ' 16' ' ' PHE . 30.2 t70 -114.06 102.19 9.94 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 179.016 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.496 ' O ' ' N ' ' A' ' 23' ' ' GLY . 55.5 mtpt -110.45 -31.23 7.34 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.942 0.401 . . . . 0.0 110.547 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.48 ' C ' ' H ' ' A' ' 24' ' ' ASP . 35.8 p30 -45.19 -15.61 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.575 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 21' ' ' LYS . . . 68.47 -8.96 1.92 Allowed Glycine 0 CA--C 1.523 0.54 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.48 ' H ' ' C ' ' A' ' 22' ' ' ASP . 43.6 p-10 -51.93 -11.6 0.17 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.86 0.362 . . . . 0.0 110.545 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.439 ' H ' ' C ' ' A' ' 23' ' ' GLY . . . 75.34 -70.49 1.88 Allowed Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 57.3 m -69.29 169.19 12.69 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.177 0.513 . . . . 0.0 110.579 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.7 pt -138.43 165.06 25.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.18 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.508 HG23 HG22 ' A' ' 62' ' ' THR . 0.2 OUTLIER -87.28 -171.23 3.38 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.117 179.946 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.427 ' H ' HG22 ' A' ' 28' ' ' THR . 59.1 t -79.08 -37.25 19.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.458 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.486 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 97.1 mt-10 -64.0 -50.22 69.36 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.669 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -42.25 -62.27 0.99 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.542 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.579 ' O ' HD13 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -60.56 -39.54 88.34 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.47 -179.644 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.486 ' HB3' ' O ' ' A' ' 30' ' ' GLU . . . -44.52 -68.05 0.23 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.146 0.498 . . . . 0.0 110.317 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.6 m -48.62 -51.65 27.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.808 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 86.2 t -50.62 -31.87 9.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.694 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.53 HD13 HD12 ' A' ' 32' ' ' LEU . 1.0 OUTLIER -67.2 -35.58 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.566 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -68.03 -42.61 80.33 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.951 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.0 p -68.01 -38.68 82.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.87 0.367 . . . . 0.0 110.818 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.456 ' O ' ' N ' ' A' ' 41' ' ' GLN . 55.9 mt -61.41 124.15 19.82 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.912 0.386 . . . . 0.0 110.099 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -64.93 66.83 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.754 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.456 ' N ' ' O ' ' A' ' 39' ' ' LEU . 37.2 tt0 -141.0 173.75 11.17 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.122 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.402 ' H ' ' HG2' ' A' ' 41' ' ' GLN . 2.7 m120 -143.43 67.41 16.54 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.823 0.344 . . . . 0.0 110.419 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -83.09 143.38 11.4 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.769 2.313 . . . . 0.0 112.096 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 40.6 p -65.87 132.41 48.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.345 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -72.16 -34.49 68.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.642 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -51.33 -44.55 62.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.453 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -57.28 -59.86 4.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.569 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.457 ' N ' HD12 ' A' ' 48' ' ' LEU . 9.6 mp -44.33 -46.06 9.08 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.467 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -57.9 -47.41 82.87 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.424 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -64.14 -50.77 66.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.158 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.554 ' O ' ' N ' ' A' ' 55' ' ' VAL . 77.2 mmm -63.67 -63.63 1.12 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.333 -179.103 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 31.3 mm -43.37 -47.42 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.336 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.8 t -71.92 -21.8 61.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.691 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.501 ' N ' ' O ' ' A' ' 51' ' ' MET . 53.2 tt0 -107.21 9.19 30.25 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 120.823 0.344 . . . . 0.0 110.578 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.554 ' N ' ' O ' ' A' ' 51' ' ' MET . 73.2 t -123.09 -38.38 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-O 120.839 0.352 . . . . 0.0 110.385 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -55.02 85.55 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.481 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -72.05 -50.05 31.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.447 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.427 ' OD2' ' OE2' ' A' ' 64' ' ' GLU . 17.4 m-20 -47.05 -28.59 1.76 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.412 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.83 10.33 86.12 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.934 -0.867 . . . . 0.0 110.934 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.52 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 36.3 p-10 -89.49 -1.87 58.18 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.773 0.32 . . . . 0.0 110.565 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 63.91 45.2 94.72 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.52 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 72.1 p -138.4 154.7 48.91 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.878 0.37 . . . . 0.0 110.549 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 87.8 mt -90.58 154.09 3.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.238 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.44 ' H ' ' HB2' ' A' ' 67' ' ' GLU . 54.4 mt-10 -146.48 -179.26 6.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.395 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -52.83 -78.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.541 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -44.62 -54.03 6.56 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.62 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.44 ' HB2' ' H ' ' A' ' 64' ' ' GLU . 98.2 mt-10 -50.25 -39.57 45.31 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.77 0.319 . . . . 0.0 110.668 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 76.1 t80 . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 120.914 0.388 . . . . 0.0 110.83 179.926 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 50.0 mt . . . . . 0 N--CA 1.456 -0.155 0 CA-C-O 120.845 0.355 . . . . 0.0 110.384 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.425 ' O ' ' N ' ' A' ' 8' ' ' GLN . 0.3 OUTLIER -95.43 125.5 40.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.43 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.467 ' O ' ' N ' ' A' ' 9' ' ' ILE . 80.4 tt0 -37.18 -72.21 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.149 0.5 . . . . 0.0 111.455 -179.377 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -47.13 -29.0 2.01 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.91 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.425 ' N ' ' O ' ' A' ' 5' ' ' SER . 45.4 tt0 -79.79 -24.72 41.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.518 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.467 ' N ' ' O ' ' A' ' 6' ' ' GLU . 3.2 tp -68.23 -36.27 74.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.8 t -76.33 -44.9 35.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.834 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -54.36 -50.23 67.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.731 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -66.34 -43.6 85.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.352 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -56.8 -42.68 79.93 Favored 'General case' 0 C--N 1.328 -0.37 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.427 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.3 tp10 -58.78 -45.97 88.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.419 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.99 -30.53 68.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.456 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -69.33 -49.25 57.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.768 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -65.23 -30.4 77.7 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 44.1 mt -72.57 -40.51 66.58 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.537 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -87.86 -14.93 38.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.439 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -113.81 101.81 9.64 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 179.075 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.505 ' O ' ' N ' ' A' ' 23' ' ' GLY . 55.8 mtpt -110.2 -31.35 7.36 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.859 0.362 . . . . 0.0 110.489 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.471 ' C ' ' H ' ' A' ' 24' ' ' ASP . 35.9 p30 -44.9 -15.58 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.565 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 21' ' ' LYS . . . 68.96 -9.7 1.91 Allowed Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.471 ' H ' ' C ' ' A' ' 22' ' ' ASP . 42.0 p-10 -51.25 -11.95 0.12 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.847 0.356 . . . . 0.0 110.51 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.444 ' H ' ' C ' ' A' ' 23' ' ' GLY . . . 76.03 -70.56 2.05 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 55.9 m -69.65 169.75 12.15 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.125 0.488 . . . . 0.0 110.71 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.45 ' O ' ' O ' ' A' ' 63' ' ' ILE . 6.3 pt -138.25 165.54 25.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.304 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.469 HG23 HG22 ' A' ' 62' ' ' THR . 0.2 OUTLIER -87.7 -170.4 2.99 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.073 179.954 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.432 ' H ' HG22 ' A' ' 28' ' ' THR . 60.3 t -79.79 -36.36 17.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.51 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.504 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 96.6 mt-10 -65.04 -50.34 66.58 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.628 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -42.12 -62.62 0.9 Allowed 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.51 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.582 ' O ' HD13 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -59.99 -39.79 86.95 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.453 -179.436 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.504 ' HB3' ' O ' ' A' ' 30' ' ' GLU . . . -43.98 -68.25 0.21 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.011 0.434 . . . . 0.0 110.435 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.9 m -49.2 -51.38 33.28 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.781 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 91.7 t -50.6 -30.6 8.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.609 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.522 HD13 HD12 ' A' ' 32' ' ' LEU . 1.0 OUTLIER -69.03 -34.58 64.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.48 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -68.79 -42.69 77.03 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.868 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.1 p -67.52 -39.75 85.07 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.73 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.462 ' O ' ' N ' ' A' ' 41' ' ' GLN . 51.4 mt -60.45 125.01 22.08 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.912 0.387 . . . . 0.0 110.129 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -65.07 66.27 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.801 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.462 ' N ' ' O ' ' A' ' 39' ' ' LEU . 37.0 tt0 -140.0 172.88 12.13 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.241 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -142.76 67.37 18.52 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-O 120.871 0.367 . . . . 0.0 110.484 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -83.24 143.15 11.11 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.743 2.296 . . . . 0.0 111.956 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 22.9 p -64.28 130.71 44.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.269 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -71.35 -37.06 71.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.726 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -49.57 -42.32 44.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.341 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -58.38 -58.8 6.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.552 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.469 ' N ' HD12 ' A' ' 48' ' ' LEU . 9.6 mp -43.07 -46.04 5.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.599 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -57.92 -48.22 80.54 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.756 -0.377 . . . . 0.0 110.306 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -64.55 -50.81 65.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.071 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.557 ' O ' ' N ' ' A' ' 55' ' ' VAL . 87.1 mmm -63.08 -65.88 0.62 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.725 0.298 . . . . 0.0 111.153 -179.036 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 38.3 mm -43.54 -46.46 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.506 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.3 t -74.75 -20.56 59.77 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.606 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.496 ' N ' ' O ' ' A' ' 51' ' ' MET . 36.5 tt0 -106.38 7.89 31.37 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.787 0.327 . . . . 0.0 110.647 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.557 ' N ' ' O ' ' A' ' 51' ' ' MET . 71.8 t -123.82 -34.34 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 120.836 0.35 . . . . 0.0 110.495 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -55.6 85.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.595 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.473 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -72.03 -50.88 24.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.432 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.429 ' OD2' ' OE2' ' A' ' 64' ' ' GLU . 12.3 m-20 -45.74 -27.17 0.76 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.498 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.13 9.96 85.4 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.519 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 41.9 p30 -90.68 -0.83 57.82 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.807 0.337 . . . . 0.0 110.514 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 63.53 46.56 92.09 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.519 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 80.9 p -138.79 158.74 43.66 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.934 0.397 . . . . 0.0 110.338 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.45 ' O ' ' O ' ' A' ' 27' ' ' ILE . 87.4 mt -94.39 146.74 6.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.275 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.443 ' H ' ' HB2' ' A' ' 67' ' ' GLU . 78.9 mt-10 -140.33 -179.85 6.23 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.326 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -53.24 -79.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.557 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -43.99 -53.43 6.24 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.499 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.443 ' HB2' ' H ' ' A' ' 64' ' ' GLU . 96.6 mt-10 -49.43 -38.89 30.9 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.601 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 70.0 t80 . . . . . 0 C--N 1.326 -0.417 0 CA-C-O 120.923 0.392 . . . . 0.0 110.783 -179.967 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 19.1 mt . . . . . 0 CA--C 1.521 -0.142 0 CA-C-O 120.9 0.381 . . . . 0.0 110.325 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.412 ' O ' ' N ' ' A' ' 8' ' ' GLN . 0.3 OUTLIER -96.88 124.82 40.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.414 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.459 ' O ' ' N ' ' A' ' 9' ' ' ILE . 80.3 tt0 -37.67 -71.42 0.08 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.36 0.6 . . . . 0.0 111.535 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -46.64 -29.3 1.79 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.937 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.412 ' N ' ' O ' ' A' ' 5' ' ' SER . 45.4 tt0 -79.41 -25.67 42.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.579 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.459 ' N ' ' O ' ' A' ' 6' ' ' GLU . 3.1 tp -66.84 -36.38 77.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.1 t -76.79 -44.5 32.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.58 -178.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -53.45 -50.91 64.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.655 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -66.08 -44.46 84.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.337 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -55.45 -43.86 75.83 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.792 0.33 . . . . 0.0 110.431 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 -57.7 -45.12 86.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.443 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.09 -30.32 68.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.478 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -69.74 -50.78 40.1 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.738 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -62.9 -32.57 84.37 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 45.6 mt -69.78 -40.29 76.13 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.819 -0.353 . . . . 0.0 110.479 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -86.55 -13.26 46.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.426 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -116.45 102.08 9.2 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.495 ' C ' ' N ' ' A' ' 23' ' ' GLY . 55.5 mtpt -109.97 -32.38 7.06 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.853 0.359 . . . . 0.0 110.552 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.467 ' C ' ' H ' ' A' ' 24' ' ' ASP . 29.5 p30 -46.71 -13.53 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.553 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.495 ' N ' ' C ' ' A' ' 21' ' ' LYS . . . 66.21 -5.78 1.93 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.467 ' H ' ' C ' ' A' ' 22' ' ' ASP . 51.2 p-10 -54.16 -10.11 0.33 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.794 0.331 . . . . 0.0 110.558 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.43 ' H ' ' C ' ' A' ' 23' ' ' GLY . . . 75.79 -71.78 1.86 Allowed Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 88.4 m -67.91 168.64 11.31 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.35 0.595 . . . . 0.0 110.445 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.431 ' O ' ' O ' ' A' ' 63' ' ' ILE . 6.8 pt -136.78 164.9 29.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.379 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.796 HG22 ' H ' ' A' ' 29' ' ' VAL . 27.0 m -86.87 178.51 6.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.483 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.796 ' H ' HG22 ' A' ' 28' ' ' THR . 93.5 t -72.57 -43.8 61.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.357 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.451 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 97.2 mt-10 -61.31 -48.12 82.81 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.325 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -42.13 -62.54 0.91 Allowed 'General case' 0 C--O 1.236 0.393 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.2 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.58 ' O ' HD13 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -62.52 -40.41 96.68 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.462 -179.722 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' ' 30' ' ' GLU . . . -44.13 -67.67 0.26 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.234 0.54 . . . . 0.0 110.552 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.8 m -48.45 -51.41 27.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.686 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 86.0 t -51.21 -30.94 10.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.712 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.532 HD13 HD12 ' A' ' 32' ' ' LEU . 1.0 OUTLIER -67.19 -34.02 66.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.804 179.557 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -69.91 -41.56 74.51 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.642 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.2 p -68.07 -39.55 82.93 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.592 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.49 ' O ' ' N ' ' A' ' 41' ' ' GLN . 55.4 mt -60.54 124.82 21.5 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.242 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -64.04 66.9 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.76 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.49 ' N ' ' O ' ' A' ' 39' ' ' LEU . 36.3 tt0 -141.59 173.38 11.55 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.304 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.407 ' H ' ' HG2' ' A' ' 41' ' ' GLN . 2.3 m120 -143.64 67.59 16.22 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.543 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -82.81 143.86 12.0 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.772 2.315 . . . . 0.0 112.138 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 47.2 p -66.08 131.44 46.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.383 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -72.4 -35.33 68.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.676 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.91 -43.46 49.65 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.545 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -57.92 -58.72 7.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.581 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.482 ' N ' HD12 ' A' ' 48' ' ' LEU . 9.7 mp -44.3 -46.28 9.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.481 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -57.95 -46.66 84.74 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.515 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -64.56 -51.14 64.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.038 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.549 ' O ' ' N ' ' A' ' 55' ' ' VAL . 79.6 mmm -62.81 -64.15 1.0 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.053 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 32.1 mm -42.76 -47.96 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.654 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 37.8 t -72.16 -21.62 61.42 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.65 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.512 ' N ' ' O ' ' A' ' 51' ' ' MET . 51.1 tt0 -106.76 9.56 31.06 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.741 0.305 . . . . 0.0 110.536 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.549 ' N ' ' O ' ' A' ' 51' ' ' MET . 78.7 t -124.03 -38.95 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-O 120.777 0.322 . . . . 0.0 110.485 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -53.54 85.66 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.646 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -76.96 -45.86 26.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.478 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -51.06 -32.14 20.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.554 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 80.51 8.57 87.42 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.526 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 34.4 p-10 -87.31 -3.26 59.03 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.768 0.318 . . . . 0.0 110.561 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 64.35 47.12 87.79 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.526 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 79.3 p -142.76 153.45 43.3 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.881 0.372 . . . . 0.0 110.536 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.431 ' O ' ' O ' ' A' ' 27' ' ' ILE . 97.5 mt -88.51 155.61 3.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.207 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.448 ' H ' ' HB2' ' A' ' 67' ' ' GLU . 21.6 mt-10 -145.86 -178.33 6.05 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.428 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -53.71 -76.61 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.382 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -46.19 -54.82 8.05 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.972 -0.291 . . . . 0.0 110.663 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.448 ' HB2' ' H ' ' A' ' 64' ' ' GLU . 93.8 mt-10 -50.31 -40.62 49.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.903 0.383 . . . . 0.0 110.638 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 87.5 t80 . . . . . 0 C--N 1.329 -0.322 0 CA-C-O 121.058 0.456 . . . . 0.0 110.796 -179.967 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 52.5 mt . . . . . 0 N--CA 1.456 -0.14 0 CA-C-O 120.862 0.363 . . . . 0.0 110.228 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.443 ' O ' ' N ' ' A' ' 8' ' ' GLN . 0.2 OUTLIER -100.13 126.11 46.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.452 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.446 ' O ' ' N ' ' A' ' 9' ' ' ILE . 80.2 tt0 -36.73 -72.3 0.06 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.219 0.533 . . . . 0.0 111.485 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -46.78 -28.91 1.69 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.887 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.443 ' N ' ' O ' ' A' ' 5' ' ' SER . 44.4 tt0 -79.94 -26.32 40.14 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.608 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.446 ' N ' ' O ' ' A' ' 6' ' ' GLU . 3.2 tp -66.64 -35.64 75.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.0 t -77.48 -44.37 29.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.61 -179.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -54.06 -50.44 66.74 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.606 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -66.64 -44.35 82.18 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.397 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -56.12 -43.11 77.87 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.478 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.4 tp10 -59.28 -45.54 90.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.413 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.29 -32.71 73.05 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.426 179.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.414 ' O ' ' N ' ' A' ' 20' ' ' ASP . 33.9 t80 -68.61 -48.57 63.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.605 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -63.04 -32.22 83.38 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 45.8 mt -70.37 -39.23 74.71 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.575 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -88.66 -14.8 36.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.481 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 16' ' ' PHE . 29.7 t70 -115.57 102.17 9.54 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.594 -0.275 . . . . 0.0 110.315 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.492 ' C ' ' N ' ' A' ' 23' ' ' GLY . 55.1 mtpt -112.53 -30.06 7.26 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.833 0.349 . . . . 0.0 110.529 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.476 ' C ' ' H ' ' A' ' 24' ' ' ASP . 34.2 p30 -45.78 -15.14 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.55 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.492 ' N ' ' C ' ' A' ' 21' ' ' LYS . . . 66.7 -6.65 1.81 Allowed Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.476 ' H ' ' C ' ' A' ' 22' ' ' ASP . 50.0 p-10 -53.96 -10.68 0.35 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.836 0.351 . . . . 0.0 110.499 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.419 ' H ' ' C ' ' A' ' 23' ' ' GLY . . . 75.56 -71.88 1.79 Allowed Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 59.3 m -67.93 168.48 11.66 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.148 0.499 . . . . 0.0 110.485 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.465 ' CD1' HD23 ' A' ' 32' ' ' LEU . 3.7 pt -137.0 164.93 29.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.252 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.438 HG23 HG22 ' A' ' 62' ' ' THR . 0.2 OUTLIER -88.76 -174.43 4.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.253 -179.854 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.431 ' H ' HG22 ' A' ' 28' ' ' THR . 86.5 t -78.44 -37.44 21.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.339 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.5 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 96.7 mt-10 -65.64 -50.88 63.37 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.594 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -41.79 -61.34 1.13 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.409 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.582 ' O ' HD13 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -61.06 -39.99 91.95 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.598 -179.546 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' A' ' 30' ' ' GLU . . . -43.74 -68.2 0.22 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.136 0.494 . . . . 0.0 110.623 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 16.2 m -48.62 -51.62 27.19 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.667 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 81.2 t -50.61 -31.44 9.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.728 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.54 HD13 HD12 ' A' ' 32' ' ' LEU . 1.0 OUTLIER -67.65 -33.56 62.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.708 179.52 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -70.25 -42.14 72.59 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.643 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.0 p -67.47 -39.41 85.29 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.514 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.477 ' O ' ' N ' ' A' ' 41' ' ' GLN . 55.7 mt -61.06 123.4 17.55 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.99 0.424 . . . . 0.0 110.232 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -64.22 67.17 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.723 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.477 ' N ' ' O ' ' A' ' 39' ' ' LEU . 36.7 tt0 -140.73 173.24 11.68 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.259 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.403 ' H ' ' HG2' ' A' ' 41' ' ' GLN . 3.0 m120 -143.61 67.8 16.4 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.418 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -82.99 143.72 11.67 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.831 2.354 . . . . 0.0 112.071 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 49.4 p -66.11 132.4 48.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.192 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -72.54 -33.92 67.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.638 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -52.15 -44.83 64.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.409 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -57.57 -59.83 4.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.624 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.436 ' N ' HD12 ' A' ' 48' ' ' LEU . 9.7 mp -44.09 -45.99 8.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.408 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -58.05 -46.82 84.73 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.471 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -64.95 -50.99 64.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.089 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.555 ' O ' ' N ' ' A' ' 55' ' ' VAL . 80.5 mmm -62.95 -63.99 1.05 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.153 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 32.2 mm -42.79 -47.72 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.78 0.324 . . . . 0.0 110.719 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 37.3 t -72.29 -21.46 61.35 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.591 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.515 ' N ' ' O ' ' A' ' 51' ' ' MET . 53.0 tt0 -107.16 9.22 30.35 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.771 0.32 . . . . 0.0 110.626 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.555 ' N ' ' O ' ' A' ' 51' ' ' MET . 73.4 t -123.55 -37.68 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.338 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -54.71 85.49 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.922 0.391 . . . . 0.0 110.581 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.496 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -71.98 -49.97 32.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.52 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.419 ' OD2' ' OE2' ' A' ' 64' ' ' GLU . 10.9 m-20 -46.89 -28.8 1.71 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.436 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.97 9.74 86.57 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.522 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 44.4 p-10 -91.39 -0.44 57.64 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.83 0.348 . . . . 0.0 110.547 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 62.06 54.02 38.15 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.522 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 78.4 p -145.37 152.83 40.48 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.877 0.37 . . . . 0.0 110.452 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.425 ' O ' ' O ' ' A' ' 27' ' ' ILE . 97.1 mt -88.8 151.82 3.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.239 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.437 ' H ' ' HB2' ' A' ' 67' ' ' GLU . 35.0 mt-10 -146.08 -178.49 6.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.46 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -53.3 -77.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.501 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -46.09 -54.04 9.24 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.585 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.437 ' HB2' ' H ' ' A' ' 64' ' ' GLU . 95.0 mt-10 -50.24 -40.42 47.67 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.984 0.421 . . . . 0.0 110.659 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 86.5 t80 . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 120.989 0.423 . . . . 0.0 110.666 -179.984 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.482 ' CG ' ' H ' ' A' ' 3' ' ' ILE . 31.6 t70 -159.15 -178.38 7.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.288 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.482 ' H ' ' CG ' ' A' ' 2' ' ' ASP . 97.0 mt -134.93 150.91 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.268 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 48.2 mt -57.41 160.47 4.06 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.404 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.404 ' O ' ' N ' ' A' ' 8' ' ' GLN . 0.3 OUTLIER -92.99 125.91 37.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.449 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.467 ' O ' ' N ' ' A' ' 9' ' ' ILE . 80.7 tt0 -37.3 -72.47 0.06 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.281 0.562 . . . . 0.0 111.621 -179.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -47.51 -28.85 2.4 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.947 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.404 ' N ' ' O ' ' A' ' 5' ' ' SER . 44.9 tt0 -79.42 -24.65 42.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.399 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.467 ' N ' ' O ' ' A' ' 6' ' ' GLU . 3.4 tp -68.51 -36.92 76.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.3 t -75.23 -44.6 42.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.022 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -54.95 -50.24 69.39 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.642 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -66.52 -44.09 83.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.295 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -56.54 -42.74 78.99 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.404 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.9 tp10 -58.76 -46.09 88.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.367 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.92 -30.64 69.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.454 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -69.24 -48.95 60.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.853 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -65.82 -30.1 76.48 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 44.1 mt -72.74 -40.58 65.96 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.487 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -87.45 -15.2 38.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.481 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -113.82 101.82 9.64 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 110.213 -0.292 . . . . 0.0 110.213 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.505 ' O ' ' N ' ' A' ' 23' ' ' GLY . 55.2 mtpt -109.89 -31.68 7.32 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.011 0.434 . . . . 0.0 110.508 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.469 ' C ' ' H ' ' A' ' 24' ' ' ASP . 38.2 p30 -44.78 -15.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.554 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 21' ' ' LYS . . . 69.18 -10.15 1.9 Allowed Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.469 ' H ' ' C ' ' A' ' 22' ' ' ASP . 35.6 p-10 -50.37 -11.61 0.08 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.743 0.306 . . . . 0.0 110.476 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.469 ' H ' ' C ' ' A' ' 23' ' ' GLY . . . 75.8 -70.51 2.0 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 60.4 m -70.08 169.82 12.68 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.078 0.466 . . . . 0.0 110.767 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.44 ' O ' ' O ' ' A' ' 63' ' ' ILE . 6.3 pt -138.24 165.0 26.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.362 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 49.8 p -86.45 -170.95 3.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.493 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 72.5 t -79.44 -36.81 18.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.5 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.485 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 96.5 mt-10 -64.57 -50.02 68.88 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.733 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -42.24 -62.1 1.02 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.588 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.576 ' O ' HD13 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -60.65 -39.65 89.13 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.475 -179.647 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' A' ' 30' ' ' GLU . . . -44.19 -67.98 0.24 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.11 0.481 . . . . 0.0 110.426 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 19.6 m -49.19 -51.4 33.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.749 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 89.7 t -50.79 -30.76 9.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.693 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.524 HD13 HD12 ' A' ' 32' ' ' LEU . 1.0 OUTLIER -68.42 -35.72 71.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.476 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -67.64 -42.74 81.77 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.628 -0.429 . . . . 0.0 111.022 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.1 p -67.82 -39.2 83.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.784 0.326 . . . . 0.0 110.897 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.454 ' O ' ' N ' ' A' ' 41' ' ' GLN . 52.7 mt -61.26 125.45 23.8 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.994 0.426 . . . . 0.0 109.999 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -65.22 66.19 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.826 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.454 ' N ' ' O ' ' A' ' 39' ' ' LEU . 37.3 tt0 -140.48 173.55 11.39 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.146 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.4 ' H ' ' HG2' ' A' ' 41' ' ' GLN . 2.6 m120 -143.33 67.34 16.69 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.749 0.309 . . . . 0.0 110.346 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.41 ' HB2' ' HZ1' ' A' ' 75' ' ' LYS . 71.6 Cg_endo -83.13 143.06 11.2 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.681 2.254 . . . . 0.0 111.995 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 31.5 p -64.47 130.59 44.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.374 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -71.81 -36.61 70.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.63 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -49.2 -41.98 38.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.332 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -58.59 -57.6 12.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.498 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.486 ' N ' HD12 ' A' ' 48' ' ' LEU . 9.6 mp -43.62 -46.42 7.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.546 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -57.56 -48.59 78.92 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.295 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -64.07 -50.76 67.09 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.183 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.531 ' O ' ' N ' ' A' ' 55' ' ' VAL . 65.6 mmm -63.45 -65.46 0.68 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.33 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 39.1 mm -44.79 -46.59 2.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.3 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.3 t -73.55 -20.34 60.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.594 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' A' ' 51' ' ' MET . 34.6 tt0 -106.59 8.83 31.43 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.785 0.326 . . . . 0.0 110.701 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.531 ' N ' ' O ' ' A' ' 51' ' ' MET . 75.0 t -124.09 -36.49 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 120.811 0.339 . . . . 0.0 110.442 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.4 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 32.4 t0 -54.35 86.15 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.628 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -73.89 -49.41 25.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.41 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.429 ' OD2' ' OE1' ' A' ' 64' ' ' GLU . 17.1 m-20 -48.94 -28.57 3.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.45 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.83 12.04 84.9 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.518 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 28.3 p30 -90.29 -0.77 57.78 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.783 0.325 . . . . 0.0 110.531 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.4 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 64.16 40.83 98.4 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.518 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 54.4 p -136.93 152.23 49.95 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.848 0.356 . . . . 0.0 110.406 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.44 ' O ' ' O ' ' A' ' 27' ' ' ILE . 82.3 mt -87.89 153.07 3.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.342 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.443 ' H ' ' HB2' ' A' ' 67' ' ' GLU . 57.0 mt-10 -142.12 179.52 6.85 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.347 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -52.91 -79.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.475 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -44.46 -53.26 7.11 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.493 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.443 ' HB2' ' H ' ' A' ' 64' ' ' GLU . 95.7 mt-10 -49.04 -38.0 22.5 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.719 179.413 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -73.44 -40.6 64.09 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.884 -0.327 . . . . 0.0 110.877 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 78.4 mt -65.98 -40.29 91.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.478 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 78.0 p -62.77 -42.56 99.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.522 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.3 tt -58.94 -39.84 82.85 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.67 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 80.4 mmm -72.01 -43.92 64.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.786 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -49.4 -45.59 46.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.779 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -80.89 -48.08 12.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.581 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.41 ' HZ1' ' HB2' ' A' ' 43' ' ' PRO . 86.3 tttt -60.18 -56.25 23.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.577 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 42.9 t . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.489 179.897 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.474 ' CG ' ' H ' ' A' ' 3' ' ' ILE . 44.9 t0 -160.14 -178.64 7.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.307 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.474 ' H ' ' CG ' ' A' ' 2' ' ' ASP . 97.1 mt -135.47 150.12 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.355 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 46.6 mt -56.65 167.08 0.79 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.396 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.432 ' O ' ' N ' ' A' ' 8' ' ' GLN . 0.2 OUTLIER -99.8 126.7 45.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.36 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.443 ' O ' ' N ' ' A' ' 9' ' ' ILE . 80.2 tt0 -36.69 -72.11 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.138 0.494 . . . . 0.0 111.571 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -47.71 -28.54 2.5 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.929 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.432 ' N ' ' O ' ' A' ' 5' ' ' SER . 44.0 tt0 -79.76 -25.99 40.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.475 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.443 ' N ' ' O ' ' A' ' 6' ' ' GLU . 3.2 tp -67.25 -36.27 76.27 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 61.7 t -76.02 -44.36 37.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.913 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -55.2 -49.87 70.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.743 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -66.93 -43.97 81.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.365 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -57.04 -42.72 80.98 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.815 0.34 . . . . 0.0 110.366 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.1 tp10 -58.96 -45.13 91.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.377 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.8 -31.6 70.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.43 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.421 ' O ' ' N ' ' A' ' 20' ' ' ASP . 28.9 t80 -69.01 -49.76 54.85 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.814 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -63.66 -31.58 81.25 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 46.5 mt -71.8 -40.03 69.47 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.48 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -87.29 -15.83 36.9 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.513 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.421 ' N ' ' O ' ' A' ' 16' ' ' PHE . 30.2 t70 -114.06 102.19 9.94 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 179.016 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.496 ' O ' ' N ' ' A' ' 23' ' ' GLY . 55.5 mtpt -110.45 -31.23 7.34 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.942 0.401 . . . . 0.0 110.547 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.48 ' C ' ' H ' ' A' ' 24' ' ' ASP . 35.8 p30 -45.19 -15.61 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.575 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 21' ' ' LYS . . . 68.47 -8.96 1.92 Allowed Glycine 0 CA--C 1.523 0.54 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.48 ' H ' ' C ' ' A' ' 22' ' ' ASP . 43.6 p-10 -51.93 -11.6 0.17 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.86 0.362 . . . . 0.0 110.545 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.439 ' H ' ' C ' ' A' ' 23' ' ' GLY . . . 75.34 -70.49 1.88 Allowed Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 57.3 m -69.29 169.19 12.69 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.177 0.513 . . . . 0.0 110.579 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.7 pt -138.43 165.06 25.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.18 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.508 HG23 HG22 ' A' ' 62' ' ' THR . 0.2 OUTLIER -87.28 -171.23 3.38 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.117 179.946 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.427 ' H ' HG22 ' A' ' 28' ' ' THR . 59.1 t -79.08 -37.25 19.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.458 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.486 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 97.1 mt-10 -64.0 -50.22 69.36 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.669 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -42.25 -62.27 0.99 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.542 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.579 ' O ' HD13 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -60.56 -39.54 88.34 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.47 -179.644 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.486 ' HB3' ' O ' ' A' ' 30' ' ' GLU . . . -44.52 -68.05 0.23 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.146 0.498 . . . . 0.0 110.317 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.6 m -48.62 -51.65 27.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.808 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 86.2 t -50.62 -31.87 9.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.694 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.53 HD13 HD12 ' A' ' 32' ' ' LEU . 1.0 OUTLIER -67.2 -35.58 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.566 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -68.03 -42.61 80.33 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.951 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.0 p -68.01 -38.68 82.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.87 0.367 . . . . 0.0 110.818 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.456 ' O ' ' N ' ' A' ' 41' ' ' GLN . 55.9 mt -61.41 124.15 19.82 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.912 0.386 . . . . 0.0 110.099 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -64.93 66.83 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.754 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.481 ' OE1' ' NZ ' ' A' ' 75' ' ' LYS . 5.3 tt0 -141.0 173.75 11.17 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.122 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.402 ' H ' ' HG2' ' A' ' 41' ' ' GLN . 2.7 m120 -143.43 67.41 16.54 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.823 0.344 . . . . 0.0 110.419 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -83.09 143.38 11.4 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.769 2.313 . . . . 0.0 112.096 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 40.6 p -65.87 132.41 48.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.345 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -72.16 -34.49 68.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.642 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -51.33 -44.55 62.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.453 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -57.28 -59.86 4.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.569 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.457 ' N ' HD12 ' A' ' 48' ' ' LEU . 9.6 mp -44.33 -46.06 9.08 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.467 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -57.9 -47.41 82.87 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.424 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -64.14 -50.77 66.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.158 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.554 ' O ' ' N ' ' A' ' 55' ' ' VAL . 77.2 mmm -63.67 -63.63 1.12 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.333 -179.103 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 31.3 mm -43.37 -47.42 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.336 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.8 t -71.92 -21.8 61.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.691 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.501 ' N ' ' O ' ' A' ' 51' ' ' MET . 53.2 tt0 -107.21 9.19 30.25 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 120.823 0.344 . . . . 0.0 110.578 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.554 ' N ' ' O ' ' A' ' 51' ' ' MET . 73.2 t -123.09 -38.38 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-O 120.839 0.352 . . . . 0.0 110.385 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -55.02 85.55 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.481 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -72.05 -50.05 31.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.447 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.427 ' OD2' ' OE2' ' A' ' 64' ' ' GLU . 17.4 m-20 -47.05 -28.59 1.76 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.412 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.83 10.33 86.12 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.934 -0.867 . . . . 0.0 110.934 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.52 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 36.3 p-10 -89.49 -1.87 58.18 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.773 0.32 . . . . 0.0 110.565 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 63.91 45.2 94.72 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.52 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 72.1 p -138.4 154.7 48.91 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.878 0.37 . . . . 0.0 110.549 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 87.8 mt -90.58 154.09 3.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.238 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.44 ' H ' ' HB2' ' A' ' 67' ' ' GLU . 54.4 mt-10 -146.48 -179.26 6.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.395 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -52.83 -78.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.541 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -44.62 -54.03 6.56 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.62 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.44 ' HB2' ' H ' ' A' ' 64' ' ' GLU . 98.2 mt-10 -50.25 -39.57 45.31 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.77 0.319 . . . . 0.0 110.668 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -71.04 -43.06 68.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.914 0.388 . . . . 0.0 110.83 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.0 mt -62.8 -37.02 85.05 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.31 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.405 ' OG ' ' O ' ' A' ' 67' ' ' GLU . 78.0 p -63.14 -43.15 99.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.48 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.0 tt -57.34 -40.82 78.79 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.614 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.428 ' O ' ' N ' ' A' ' 76' ' ' VAL . 80.8 mmm -70.74 -41.9 71.21 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.628 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -47.83 -44.56 29.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.567 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.1 mtpt -80.49 -50.31 10.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.615 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.481 ' NZ ' ' OE1' ' A' ' 41' ' ' GLN . 87.1 tttt -58.58 -56.82 17.2 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.502 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.428 ' N ' ' O ' ' A' ' 72' ' ' MET . 46.6 t . . . . . 0 C--O 1.221 -0.43 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.535 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.473 ' CG ' ' H ' ' A' ' 3' ' ' ILE . 44.7 t0 -160.14 -179.77 8.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.395 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.473 ' H ' ' CG ' ' A' ' 2' ' ' ASP . 97.1 mt -134.94 151.64 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-O 120.95 0.405 . . . . 0.0 110.363 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 50.0 mt -57.33 163.19 2.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.384 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.425 ' O ' ' N ' ' A' ' 8' ' ' GLN . 0.3 OUTLIER -95.43 125.5 40.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.43 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.467 ' O ' ' N ' ' A' ' 9' ' ' ILE . 80.4 tt0 -37.18 -72.21 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.149 0.5 . . . . 0.0 111.455 -179.377 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -47.13 -29.0 2.01 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.91 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.425 ' N ' ' O ' ' A' ' 5' ' ' SER . 45.4 tt0 -79.79 -24.72 41.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.518 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.467 ' N ' ' O ' ' A' ' 6' ' ' GLU . 3.2 tp -68.23 -36.27 74.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.8 t -76.33 -44.9 35.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.834 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -54.36 -50.23 67.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.731 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -66.34 -43.6 85.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.352 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -56.8 -42.68 79.93 Favored 'General case' 0 C--N 1.328 -0.37 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.427 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.3 tp10 -58.78 -45.97 88.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.419 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.99 -30.53 68.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.456 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -69.33 -49.25 57.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.768 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -65.23 -30.4 77.7 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 44.1 mt -72.57 -40.51 66.58 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.537 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -87.86 -14.93 38.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.439 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -113.81 101.81 9.64 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 179.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.505 ' O ' ' N ' ' A' ' 23' ' ' GLY . 55.8 mtpt -110.2 -31.35 7.36 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.859 0.362 . . . . 0.0 110.489 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.471 ' C ' ' H ' ' A' ' 24' ' ' ASP . 35.9 p30 -44.9 -15.58 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.565 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 21' ' ' LYS . . . 68.96 -9.7 1.91 Allowed Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.471 ' H ' ' C ' ' A' ' 22' ' ' ASP . 42.0 p-10 -51.25 -11.95 0.12 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.847 0.356 . . . . 0.0 110.51 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.444 ' H ' ' C ' ' A' ' 23' ' ' GLY . . . 76.03 -70.56 2.05 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 55.9 m -69.65 169.75 12.15 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.125 0.488 . . . . 0.0 110.71 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.45 ' O ' ' O ' ' A' ' 63' ' ' ILE . 6.3 pt -138.25 165.54 25.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.304 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.469 HG23 HG22 ' A' ' 62' ' ' THR . 0.2 OUTLIER -87.7 -170.4 2.99 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.073 179.954 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.432 ' H ' HG22 ' A' ' 28' ' ' THR . 60.3 t -79.79 -36.36 17.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.51 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.504 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 96.6 mt-10 -65.04 -50.34 66.58 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.628 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -42.12 -62.62 0.9 Allowed 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.51 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.582 ' O ' HD13 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -59.99 -39.79 86.95 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.453 -179.436 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.504 ' HB3' ' O ' ' A' ' 30' ' ' GLU . . . -43.98 -68.25 0.21 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.011 0.434 . . . . 0.0 110.435 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.9 m -49.2 -51.38 33.28 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.781 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 91.7 t -50.6 -30.6 8.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.609 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.522 HD13 HD12 ' A' ' 32' ' ' LEU . 1.0 OUTLIER -69.03 -34.58 64.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.48 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -68.79 -42.69 77.03 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.868 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.1 p -67.52 -39.75 85.07 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.73 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.462 ' O ' ' N ' ' A' ' 41' ' ' GLN . 51.4 mt -60.45 125.01 22.08 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.912 0.387 . . . . 0.0 110.129 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -65.07 66.27 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.801 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.462 ' N ' ' O ' ' A' ' 39' ' ' LEU . 37.0 tt0 -140.0 172.88 12.13 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.241 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -142.76 67.37 18.52 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-O 120.871 0.367 . . . . 0.0 110.484 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.416 ' HB3' ' HZ3' ' A' ' 75' ' ' LYS . 72.8 Cg_endo -83.24 143.15 11.11 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.743 2.296 . . . . 0.0 111.956 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 22.9 p -64.28 130.71 44.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.269 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -71.35 -37.06 71.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.726 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -49.57 -42.32 44.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.341 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -58.38 -58.8 6.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.552 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.469 ' N ' HD12 ' A' ' 48' ' ' LEU . 9.6 mp -43.07 -46.04 5.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.599 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -57.92 -48.22 80.54 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.756 -0.377 . . . . 0.0 110.306 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -64.55 -50.81 65.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.071 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.557 ' O ' ' N ' ' A' ' 55' ' ' VAL . 87.1 mmm -63.08 -65.88 0.62 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.725 0.298 . . . . 0.0 111.153 -179.036 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 38.3 mm -43.54 -46.46 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.506 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.3 t -74.75 -20.56 59.77 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.606 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.496 ' N ' ' O ' ' A' ' 51' ' ' MET . 36.5 tt0 -106.38 7.89 31.37 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.787 0.327 . . . . 0.0 110.647 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.557 ' N ' ' O ' ' A' ' 51' ' ' MET . 71.8 t -123.82 -34.34 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 120.836 0.35 . . . . 0.0 110.495 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -55.6 85.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.595 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.473 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -72.03 -50.88 24.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.432 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.429 ' OD2' ' OE2' ' A' ' 64' ' ' GLU . 12.3 m-20 -45.74 -27.17 0.76 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.498 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.13 9.96 85.4 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.519 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 41.9 p30 -90.68 -0.83 57.82 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.807 0.337 . . . . 0.0 110.514 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 63.53 46.56 92.09 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.519 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 80.9 p -138.79 158.74 43.66 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.934 0.397 . . . . 0.0 110.338 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.45 ' O ' ' O ' ' A' ' 27' ' ' ILE . 87.4 mt -94.39 146.74 6.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.275 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.443 ' H ' ' HB2' ' A' ' 67' ' ' GLU . 78.9 mt-10 -140.33 -179.85 6.23 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.326 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -53.24 -79.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.557 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -43.99 -53.43 6.24 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.499 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.443 ' HB2' ' H ' ' A' ' 64' ' ' GLU . 96.6 mt-10 -49.43 -38.89 30.9 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.601 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -72.71 -41.07 65.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.923 0.392 . . . . 0.0 110.783 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 80.6 mt -65.81 -40.02 91.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.458 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 77.7 p -62.17 -42.76 99.58 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.098 0.475 . . . . 0.0 110.473 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.3 tt -59.26 -39.6 83.36 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.721 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 79.9 mmm -72.44 -44.74 61.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.778 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -49.06 -46.28 44.2 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.884 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -80.7 -49.13 11.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.695 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.416 ' HZ3' ' HB3' ' A' ' 43' ' ' PRO . 87.6 tttt -58.27 -55.45 34.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.678 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 43.7 t . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.473 179.913 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.475 ' CG ' ' H ' ' A' ' 3' ' ' ILE . 29.1 t70 -160.03 -177.25 6.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.281 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.475 ' H ' ' CG ' ' A' ' 2' ' ' ASP . 97.4 mt -135.35 149.62 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.407 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 19.1 mt -57.69 165.41 1.68 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.325 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.412 ' O ' ' N ' ' A' ' 8' ' ' GLN . 0.3 OUTLIER -96.88 124.82 40.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.414 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.459 ' O ' ' N ' ' A' ' 9' ' ' ILE . 80.3 tt0 -37.67 -71.42 0.08 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.36 0.6 . . . . 0.0 111.535 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -46.64 -29.3 1.79 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.937 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.412 ' N ' ' O ' ' A' ' 5' ' ' SER . 45.4 tt0 -79.41 -25.67 42.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.579 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.459 ' N ' ' O ' ' A' ' 6' ' ' GLU . 3.1 tp -66.84 -36.38 77.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.1 t -76.79 -44.5 32.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.58 -178.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -53.45 -50.91 64.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.655 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -66.08 -44.46 84.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.337 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -55.45 -43.86 75.83 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.792 0.33 . . . . 0.0 110.431 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 -57.7 -45.12 86.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.443 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.09 -30.32 68.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.478 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -69.74 -50.78 40.1 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.738 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -62.9 -32.57 84.37 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 45.6 mt -69.78 -40.29 76.13 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.819 -0.353 . . . . 0.0 110.479 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -86.55 -13.26 46.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.426 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -116.45 102.08 9.2 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.495 ' C ' ' N ' ' A' ' 23' ' ' GLY . 55.5 mtpt -109.97 -32.38 7.06 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.853 0.359 . . . . 0.0 110.552 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.467 ' C ' ' H ' ' A' ' 24' ' ' ASP . 29.5 p30 -46.71 -13.53 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.553 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.495 ' N ' ' C ' ' A' ' 21' ' ' LYS . . . 66.21 -5.78 1.93 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.467 ' H ' ' C ' ' A' ' 22' ' ' ASP . 51.2 p-10 -54.16 -10.11 0.33 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.794 0.331 . . . . 0.0 110.558 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.43 ' H ' ' C ' ' A' ' 23' ' ' GLY . . . 75.79 -71.78 1.86 Allowed Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 88.4 m -67.91 168.64 11.31 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.35 0.595 . . . . 0.0 110.445 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.431 ' O ' ' O ' ' A' ' 63' ' ' ILE . 6.8 pt -136.78 164.9 29.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.379 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.796 HG22 ' H ' ' A' ' 29' ' ' VAL . 27.0 m -86.87 178.51 6.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.483 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.796 ' H ' HG22 ' A' ' 28' ' ' THR . 93.5 t -72.57 -43.8 61.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.357 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.451 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 97.2 mt-10 -61.31 -48.12 82.81 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.325 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -42.13 -62.54 0.91 Allowed 'General case' 0 C--O 1.236 0.393 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.2 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.58 ' O ' HD13 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -62.52 -40.41 96.68 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.462 -179.722 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' ' 30' ' ' GLU . . . -44.13 -67.67 0.26 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.234 0.54 . . . . 0.0 110.552 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.8 m -48.45 -51.41 27.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.686 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 86.0 t -51.21 -30.94 10.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.712 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.532 HD13 HD12 ' A' ' 32' ' ' LEU . 1.0 OUTLIER -67.19 -34.02 66.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.804 179.557 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -69.91 -41.56 74.51 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.642 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.2 p -68.07 -39.55 82.93 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.592 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.49 ' O ' ' N ' ' A' ' 41' ' ' GLN . 55.4 mt -60.54 124.82 21.5 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.242 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -64.04 66.9 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.76 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.49 ' N ' ' O ' ' A' ' 39' ' ' LEU . 5.1 tt0 -141.59 173.38 11.55 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.304 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.407 ' H ' ' HG2' ' A' ' 41' ' ' GLN . 2.3 m120 -143.64 67.59 16.22 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.543 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -82.81 143.86 12.0 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.772 2.315 . . . . 0.0 112.138 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 47.2 p -66.08 131.44 46.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.383 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -72.4 -35.33 68.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.676 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.91 -43.46 49.65 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.545 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -57.92 -58.72 7.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.581 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.482 ' N ' HD12 ' A' ' 48' ' ' LEU . 9.7 mp -44.3 -46.28 9.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.481 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -57.95 -46.66 84.74 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.515 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -64.56 -51.14 64.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.038 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.549 ' O ' ' N ' ' A' ' 55' ' ' VAL . 79.6 mmm -62.81 -64.15 1.0 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.053 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 32.1 mm -42.76 -47.96 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.654 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 37.8 t -72.16 -21.62 61.42 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.65 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.512 ' N ' ' O ' ' A' ' 51' ' ' MET . 51.1 tt0 -106.76 9.56 31.06 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.741 0.305 . . . . 0.0 110.536 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.549 ' N ' ' O ' ' A' ' 51' ' ' MET . 78.7 t -124.03 -38.95 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-O 120.777 0.322 . . . . 0.0 110.485 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -53.54 85.66 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.646 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -76.96 -45.86 26.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.478 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -51.06 -32.14 20.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.554 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 80.51 8.57 87.42 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.526 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 34.4 p-10 -87.31 -3.26 59.03 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.768 0.318 . . . . 0.0 110.561 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 64.35 47.12 87.79 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.526 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 79.3 p -142.76 153.45 43.3 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.881 0.372 . . . . 0.0 110.536 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.431 ' O ' ' O ' ' A' ' 27' ' ' ILE . 97.5 mt -88.51 155.61 3.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.207 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.448 ' H ' ' HB2' ' A' ' 67' ' ' GLU . 21.6 mt-10 -145.86 -178.33 6.05 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.428 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -53.71 -76.61 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.382 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -46.19 -54.82 8.05 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.972 -0.291 . . . . 0.0 110.663 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.448 ' HB2' ' H ' ' A' ' 64' ' ' GLU . 93.8 mt-10 -50.31 -40.62 49.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.903 0.383 . . . . 0.0 110.638 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -70.76 -43.47 68.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.058 0.456 . . . . 0.0 110.796 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 46.7 mt -63.01 -37.21 86.27 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.322 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' A' ' 67' ' ' GLU . 77.7 p -62.44 -43.03 99.81 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.237 0.541 . . . . 0.0 110.37 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.6 tt -57.43 -39.86 77.14 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.643 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 81.0 mmm -71.15 -41.16 70.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.616 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -48.91 -44.08 39.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.539 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 31.0 mtpt -80.42 -50.39 10.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.625 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.441 ' NZ ' ' OE1' ' A' ' 41' ' ' GLN . 87.0 tttt -58.06 -56.49 21.31 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.471 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.9 t . . . . . 0 C--O 1.221 -0.438 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.677 179.991 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.463 ' CG ' ' H ' ' A' ' 3' ' ' ILE . 44.8 t0 -158.61 -178.94 7.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.272 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.463 ' H ' ' CG ' ' A' ' 2' ' ' ASP . 97.2 mt -135.36 149.25 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.416 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 52.5 mt -55.83 167.64 0.55 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.228 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.443 ' O ' ' N ' ' A' ' 8' ' ' GLN . 0.2 OUTLIER -100.13 126.11 46.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.452 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.446 ' O ' ' N ' ' A' ' 9' ' ' ILE . 80.2 tt0 -36.73 -72.3 0.06 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.219 0.533 . . . . 0.0 111.485 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -46.78 -28.91 1.69 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.887 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.443 ' N ' ' O ' ' A' ' 5' ' ' SER . 44.4 tt0 -79.94 -26.32 40.14 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.608 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.446 ' N ' ' O ' ' A' ' 6' ' ' GLU . 3.2 tp -66.64 -35.64 75.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.0 t -77.48 -44.37 29.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.61 -179.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -54.06 -50.44 66.74 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.606 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -66.64 -44.35 82.18 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.397 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -56.12 -43.11 77.87 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.478 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.4 tp10 -59.28 -45.54 90.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.413 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.29 -32.71 73.05 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.426 179.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.414 ' O ' ' N ' ' A' ' 20' ' ' ASP . 33.9 t80 -68.61 -48.57 63.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.605 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -63.04 -32.22 83.38 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 45.8 mt -70.37 -39.23 74.71 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.575 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -88.66 -14.8 36.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.481 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 16' ' ' PHE . 29.7 t70 -115.57 102.17 9.54 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.594 -0.275 . . . . 0.0 110.315 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.492 ' C ' ' N ' ' A' ' 23' ' ' GLY . 55.1 mtpt -112.53 -30.06 7.26 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.833 0.349 . . . . 0.0 110.529 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.476 ' C ' ' H ' ' A' ' 24' ' ' ASP . 34.2 p30 -45.78 -15.14 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.55 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.492 ' N ' ' C ' ' A' ' 21' ' ' LYS . . . 66.7 -6.65 1.81 Allowed Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.476 ' H ' ' C ' ' A' ' 22' ' ' ASP . 50.0 p-10 -53.96 -10.68 0.35 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.836 0.351 . . . . 0.0 110.499 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.419 ' H ' ' C ' ' A' ' 23' ' ' GLY . . . 75.56 -71.88 1.79 Allowed Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 59.3 m -67.93 168.48 11.66 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.148 0.499 . . . . 0.0 110.485 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.465 ' CD1' HD23 ' A' ' 32' ' ' LEU . 3.7 pt -137.0 164.93 29.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.252 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.438 HG23 HG22 ' A' ' 62' ' ' THR . 0.2 OUTLIER -88.76 -174.43 4.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.253 -179.854 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.431 ' H ' HG22 ' A' ' 28' ' ' THR . 86.5 t -78.44 -37.44 21.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.339 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.5 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 96.7 mt-10 -65.64 -50.88 63.37 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.594 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -41.79 -61.34 1.13 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.409 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.582 ' O ' HD13 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -61.06 -39.99 91.95 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.598 -179.546 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' A' ' 30' ' ' GLU . . . -43.74 -68.2 0.22 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.136 0.494 . . . . 0.0 110.623 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 16.2 m -48.62 -51.62 27.19 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.667 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 81.2 t -50.61 -31.44 9.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.728 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.54 HD13 HD12 ' A' ' 32' ' ' LEU . 1.0 OUTLIER -67.65 -33.56 62.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.708 179.52 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -70.25 -42.14 72.59 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.643 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.0 p -67.47 -39.41 85.29 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.514 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.477 ' O ' ' N ' ' A' ' 41' ' ' GLN . 55.7 mt -61.06 123.4 17.55 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.99 0.424 . . . . 0.0 110.232 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -64.22 67.17 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.723 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.477 ' N ' ' O ' ' A' ' 39' ' ' LEU . 5.1 tt0 -140.73 173.24 11.68 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.259 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.403 ' H ' ' HG2' ' A' ' 41' ' ' GLN . 3.0 m120 -143.61 67.8 16.4 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.418 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -82.99 143.72 11.67 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.831 2.354 . . . . 0.0 112.071 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 49.4 p -66.11 132.4 48.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.192 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -72.54 -33.92 67.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.638 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -52.15 -44.83 64.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.409 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -57.57 -59.83 4.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.624 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.436 ' N ' HD12 ' A' ' 48' ' ' LEU . 9.7 mp -44.09 -45.99 8.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.408 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -58.05 -46.82 84.73 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.471 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -64.95 -50.99 64.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.089 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.555 ' O ' ' N ' ' A' ' 55' ' ' VAL . 80.5 mmm -62.95 -63.99 1.05 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.153 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 32.2 mm -42.79 -47.72 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.78 0.324 . . . . 0.0 110.719 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 37.3 t -72.29 -21.46 61.35 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.591 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.515 ' N ' ' O ' ' A' ' 51' ' ' MET . 53.0 tt0 -107.16 9.22 30.35 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.771 0.32 . . . . 0.0 110.626 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.555 ' N ' ' O ' ' A' ' 51' ' ' MET . 73.4 t -123.55 -37.68 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.338 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -54.71 85.49 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.922 0.391 . . . . 0.0 110.581 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.496 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -71.98 -49.97 32.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.52 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.419 ' OD2' ' OE2' ' A' ' 64' ' ' GLU . 10.9 m-20 -46.89 -28.8 1.71 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.436 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.97 9.74 86.57 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.522 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 44.4 p-10 -91.39 -0.44 57.64 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.83 0.348 . . . . 0.0 110.547 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 62.06 54.02 38.15 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.522 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 78.4 p -145.37 152.83 40.48 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.877 0.37 . . . . 0.0 110.452 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.425 ' O ' ' O ' ' A' ' 27' ' ' ILE . 97.1 mt -88.8 151.82 3.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.239 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.437 ' H ' ' HB2' ' A' ' 67' ' ' GLU . 35.0 mt-10 -146.08 -178.49 6.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.46 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -53.3 -77.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.501 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -46.09 -54.04 9.24 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.585 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.437 ' HB2' ' H ' ' A' ' 64' ' ' GLU . 95.0 mt-10 -50.24 -40.42 47.67 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.984 0.421 . . . . 0.0 110.659 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -70.66 -43.13 69.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.989 0.423 . . . . 0.0 110.666 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 90.3 mt -62.45 -37.53 86.26 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.321 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.405 ' OG ' ' O ' ' A' ' 67' ' ' GLU . 77.8 p -62.71 -43.02 99.89 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.164 0.507 . . . . 0.0 110.464 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.7 tt -57.14 -40.67 77.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.618 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.426 ' O ' ' N ' ' A' ' 76' ' ' VAL . 79.3 mmm -70.87 -41.27 71.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.545 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -47.93 -44.74 30.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.628 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 29.7 mtpt -80.95 -50.46 9.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.652 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.452 ' NZ ' ' OE1' ' A' ' 41' ' ' GLN . 86.5 tttt -57.87 -56.38 22.7 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.468 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.426 ' N ' ' O ' ' A' ' 72' ' ' MET . 46.3 t . . . . . 0 C--O 1.221 -0.438 0 CA-C-O 117.906 -1.045 . . . . 0.0 110.526 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 48.2 mt . . . . . 0 N--CA 1.455 -0.181 0 CA-C-O 120.938 0.399 . . . . 0.0 110.404 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.404 ' O ' ' N ' ' A' ' 8' ' ' GLN . 0.3 OUTLIER -92.99 125.91 37.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.449 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.467 ' O ' ' N ' ' A' ' 9' ' ' ILE . 80.7 tt0 -37.3 -72.47 0.06 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.281 0.562 . . . . 0.0 111.621 -179.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -47.51 -28.85 2.4 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.947 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.404 ' N ' ' O ' ' A' ' 5' ' ' SER . 44.9 tt0 -79.42 -24.65 42.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.399 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.467 ' N ' ' O ' ' A' ' 6' ' ' GLU . 3.4 tp -68.51 -36.92 76.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.3 t -75.23 -44.6 42.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.022 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -54.95 -50.24 69.39 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.642 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -66.52 -44.09 83.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.295 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -56.54 -42.74 78.99 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.404 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.9 tp10 -58.76 -46.09 88.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.367 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.92 -30.64 69.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.454 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -69.24 -48.95 60.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.853 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -65.82 -30.1 76.48 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 44.1 mt -72.74 -40.58 65.96 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.487 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -87.45 -15.2 38.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.481 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -113.82 101.82 9.64 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 110.213 -0.292 . . . . 0.0 110.213 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.505 ' O ' ' N ' ' A' ' 23' ' ' GLY . 55.2 mtpt -109.89 -31.68 7.32 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.011 0.434 . . . . 0.0 110.508 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.469 ' C ' ' H ' ' A' ' 24' ' ' ASP . 38.2 p30 -44.78 -15.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.554 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 21' ' ' LYS . . . 69.18 -10.15 1.9 Allowed Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.469 ' H ' ' C ' ' A' ' 22' ' ' ASP . 35.6 p-10 -50.37 -11.61 0.08 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.743 0.306 . . . . 0.0 110.476 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.469 ' H ' ' C ' ' A' ' 23' ' ' GLY . . . 75.8 -70.51 2.0 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 60.4 m -70.08 169.82 12.68 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.078 0.466 . . . . 0.0 110.767 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.44 ' O ' ' O ' ' A' ' 63' ' ' ILE . 6.3 pt -138.24 165.0 26.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.362 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 49.8 p -86.45 -170.95 3.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.493 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 72.5 t -79.44 -36.81 18.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.5 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.485 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 96.5 mt-10 -64.57 -50.02 68.88 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.733 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -42.24 -62.1 1.02 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.588 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.576 HD13 ' O ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -60.65 -39.65 89.13 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.475 -179.647 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' A' ' 30' ' ' GLU . . . -44.19 -67.98 0.24 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.11 0.481 . . . . 0.0 110.426 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 19.6 m -49.19 -51.4 33.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.749 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 89.7 t -50.79 -30.76 9.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.693 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.524 HD13 HD12 ' A' ' 32' ' ' LEU . 1.0 OUTLIER -68.42 -35.72 71.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.476 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -67.64 -42.74 81.77 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.628 -0.429 . . . . 0.0 111.022 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.1 p -67.82 -39.2 83.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.784 0.326 . . . . 0.0 110.897 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.454 ' O ' ' N ' ' A' ' 41' ' ' GLN . 52.7 mt -61.26 125.45 23.8 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.994 0.426 . . . . 0.0 109.999 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -65.22 66.19 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.826 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.485 ' C ' ' ND2' ' A' ' 42' ' ' ASN . 37.3 tt0 -140.48 173.55 11.39 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.146 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.485 ' ND2' ' C ' ' A' ' 41' ' ' GLN . 0.4 OUTLIER -143.33 67.34 16.69 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.749 0.309 . . . . 0.0 110.346 -179.89 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -83.13 143.06 11.2 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.681 2.254 . . . . 0.0 111.995 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 31.5 p -64.47 130.59 44.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.374 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -71.81 -36.61 70.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.63 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -49.2 -41.98 38.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.332 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -58.59 -57.6 12.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.498 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.486 ' N ' HD12 ' A' ' 48' ' ' LEU . 9.6 mp -43.62 -46.42 7.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.546 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -57.56 -48.59 78.92 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.295 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -64.07 -50.76 67.09 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.183 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.531 ' O ' ' N ' ' A' ' 55' ' ' VAL . 65.6 mmm -63.45 -65.46 0.68 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.33 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 39.1 mm -44.79 -46.59 2.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.3 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.3 t -73.55 -20.34 60.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.594 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' A' ' 51' ' ' MET . 34.6 tt0 -106.59 8.83 31.43 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.785 0.326 . . . . 0.0 110.701 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.531 ' N ' ' O ' ' A' ' 51' ' ' MET . 75.0 t -124.09 -36.49 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 120.811 0.339 . . . . 0.0 110.442 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.4 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 32.4 t0 -54.35 86.15 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.628 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -73.89 -49.41 25.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.41 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.429 ' OD2' ' OE1' ' A' ' 64' ' ' GLU . 17.1 m-20 -48.94 -28.57 3.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.45 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.83 12.04 84.9 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.518 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 28.3 p30 -90.29 -0.77 57.78 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.783 0.325 . . . . 0.0 110.531 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.4 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 64.16 40.83 98.4 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.518 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 54.4 p -136.93 152.23 49.95 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.848 0.356 . . . . 0.0 110.406 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.44 ' O ' ' O ' ' A' ' 27' ' ' ILE . 82.3 mt -87.89 153.07 3.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.342 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.443 ' H ' ' HB2' ' A' ' 67' ' ' GLU . 57.0 mt-10 -142.12 179.52 6.85 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.347 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -52.91 -79.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.475 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -44.46 -53.26 7.11 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.493 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.443 ' HB2' ' H ' ' A' ' 64' ' ' GLU . 95.7 mt-10 -49.04 -38.0 22.5 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.719 179.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 65.4 t80 . . . . . 0 C--N 1.327 -0.379 0 C-N-CA 120.884 -0.327 . . . . 0.0 110.877 179.911 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 46.6 mt . . . . . 0 N--CA 1.454 -0.26 0 CA-C-O 120.875 0.369 . . . . 0.0 110.396 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.432 ' O ' ' N ' ' A' ' 8' ' ' GLN . 0.2 OUTLIER -99.8 126.7 45.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.36 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.443 ' O ' ' N ' ' A' ' 9' ' ' ILE . 80.2 tt0 -36.69 -72.11 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.138 0.494 . . . . 0.0 111.571 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -47.71 -28.54 2.5 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.929 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.432 ' N ' ' O ' ' A' ' 5' ' ' SER . 44.0 tt0 -79.76 -25.99 40.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.475 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.443 ' N ' ' O ' ' A' ' 6' ' ' GLU . 3.2 tp -67.25 -36.27 76.27 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 61.7 t -76.02 -44.36 37.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.913 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -55.2 -49.87 70.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.743 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -66.93 -43.97 81.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.365 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -57.04 -42.72 80.98 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.815 0.34 . . . . 0.0 110.366 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.1 tp10 -58.96 -45.13 91.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.377 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.8 -31.6 70.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.43 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.421 ' O ' ' N ' ' A' ' 20' ' ' ASP . 28.9 t80 -69.01 -49.76 54.85 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.814 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -63.66 -31.58 81.25 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 46.5 mt -71.8 -40.03 69.47 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.48 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -87.29 -15.83 36.9 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.513 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.421 ' N ' ' O ' ' A' ' 16' ' ' PHE . 30.2 t70 -114.06 102.19 9.94 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 179.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.496 ' O ' ' N ' ' A' ' 23' ' ' GLY . 55.5 mtpt -110.45 -31.23 7.34 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.942 0.401 . . . . 0.0 110.547 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.48 ' C ' ' H ' ' A' ' 24' ' ' ASP . 35.8 p30 -45.19 -15.61 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.575 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 21' ' ' LYS . . . 68.47 -8.96 1.92 Allowed Glycine 0 CA--C 1.523 0.54 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.48 ' H ' ' C ' ' A' ' 22' ' ' ASP . 43.6 p-10 -51.93 -11.6 0.17 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.86 0.362 . . . . 0.0 110.545 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.439 ' H ' ' C ' ' A' ' 23' ' ' GLY . . . 75.34 -70.49 1.88 Allowed Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 57.3 m -69.29 169.19 12.69 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.177 0.513 . . . . 0.0 110.579 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.7 pt -138.43 165.06 25.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.18 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.508 HG23 HG22 ' A' ' 62' ' ' THR . 0.2 OUTLIER -87.28 -171.23 3.38 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.117 179.946 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.427 ' H ' HG22 ' A' ' 28' ' ' THR . 59.1 t -79.08 -37.25 19.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.458 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.486 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 97.1 mt-10 -64.0 -50.22 69.36 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.669 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -42.25 -62.27 0.99 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.542 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.579 HD13 ' O ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -60.56 -39.54 88.34 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.47 -179.644 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.486 ' HB3' ' O ' ' A' ' 30' ' ' GLU . . . -44.52 -68.05 0.23 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.146 0.498 . . . . 0.0 110.317 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.6 m -48.62 -51.65 27.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.808 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 86.2 t -50.62 -31.87 9.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.694 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.53 HD13 HD12 ' A' ' 32' ' ' LEU . 1.0 OUTLIER -67.2 -35.58 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.566 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -68.03 -42.61 80.33 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.951 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.0 p -68.01 -38.68 82.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.87 0.367 . . . . 0.0 110.818 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.456 ' O ' ' N ' ' A' ' 41' ' ' GLN . 55.9 mt -61.41 124.15 19.82 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.912 0.386 . . . . 0.0 110.099 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -64.93 66.83 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.754 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.487 ' C ' ' ND2' ' A' ' 42' ' ' ASN . 37.2 tt0 -141.0 173.75 11.17 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.122 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.487 ' ND2' ' C ' ' A' ' 41' ' ' GLN . 0.4 OUTLIER -143.43 67.41 16.54 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.823 0.344 . . . . 0.0 110.419 -179.925 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -83.09 143.38 11.4 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.769 2.313 . . . . 0.0 112.096 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 40.6 p -65.87 132.41 48.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.345 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -72.16 -34.49 68.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.642 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -51.33 -44.55 62.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.453 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -57.28 -59.86 4.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.569 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.457 ' N ' HD12 ' A' ' 48' ' ' LEU . 9.6 mp -44.33 -46.06 9.08 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.467 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -57.9 -47.41 82.87 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.424 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -64.14 -50.77 66.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.158 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.554 ' O ' ' N ' ' A' ' 55' ' ' VAL . 77.2 mmm -63.67 -63.63 1.12 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.333 -179.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 31.3 mm -43.37 -47.42 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.336 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.8 t -71.92 -21.8 61.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.691 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.501 ' N ' ' O ' ' A' ' 51' ' ' MET . 53.2 tt0 -107.21 9.19 30.25 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 120.823 0.344 . . . . 0.0 110.578 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.554 ' N ' ' O ' ' A' ' 51' ' ' MET . 73.2 t -123.09 -38.38 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-O 120.839 0.352 . . . . 0.0 110.385 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -55.02 85.55 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.481 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -72.05 -50.05 31.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.447 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.427 ' OD2' ' OE2' ' A' ' 64' ' ' GLU . 17.4 m-20 -47.05 -28.59 1.76 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.412 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.83 10.33 86.12 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.934 -0.867 . . . . 0.0 110.934 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.52 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 36.3 p-10 -89.49 -1.87 58.18 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.773 0.32 . . . . 0.0 110.565 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 63.91 45.2 94.72 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.52 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 72.1 p -138.4 154.7 48.91 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.878 0.37 . . . . 0.0 110.549 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 87.8 mt -90.58 154.09 3.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.238 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.44 ' H ' ' HB2' ' A' ' 67' ' ' GLU . 54.4 mt-10 -146.48 -179.26 6.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.395 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -52.83 -78.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.541 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -44.62 -54.03 6.56 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.62 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.44 ' HB2' ' H ' ' A' ' 64' ' ' GLU . 98.2 mt-10 -50.25 -39.57 45.31 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.77 0.319 . . . . 0.0 110.668 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 76.1 t80 . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 120.914 0.388 . . . . 0.0 110.83 179.926 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 50.0 mt . . . . . 0 N--CA 1.456 -0.155 0 CA-C-O 120.845 0.355 . . . . 0.0 110.384 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.425 ' O ' ' N ' ' A' ' 8' ' ' GLN . 0.3 OUTLIER -95.43 125.5 40.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.43 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.467 ' O ' ' N ' ' A' ' 9' ' ' ILE . 80.4 tt0 -37.18 -72.21 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.149 0.5 . . . . 0.0 111.455 -179.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -47.13 -29.0 2.01 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.91 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.425 ' N ' ' O ' ' A' ' 5' ' ' SER . 45.4 tt0 -79.79 -24.72 41.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.518 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.467 ' N ' ' O ' ' A' ' 6' ' ' GLU . 3.2 tp -68.23 -36.27 74.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.8 t -76.33 -44.9 35.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.834 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -54.36 -50.23 67.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.731 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -66.34 -43.6 85.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.352 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -56.8 -42.68 79.93 Favored 'General case' 0 C--N 1.328 -0.37 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.427 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.3 tp10 -58.78 -45.97 88.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.419 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.99 -30.53 68.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.456 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -69.33 -49.25 57.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.768 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -65.23 -30.4 77.7 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 44.1 mt -72.57 -40.51 66.58 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.537 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -87.86 -14.93 38.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.439 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -113.81 101.81 9.64 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 179.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.505 ' O ' ' N ' ' A' ' 23' ' ' GLY . 55.8 mtpt -110.2 -31.35 7.36 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.859 0.362 . . . . 0.0 110.489 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.471 ' C ' ' H ' ' A' ' 24' ' ' ASP . 35.9 p30 -44.9 -15.58 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.565 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 21' ' ' LYS . . . 68.96 -9.7 1.91 Allowed Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.471 ' H ' ' C ' ' A' ' 22' ' ' ASP . 42.0 p-10 -51.25 -11.95 0.12 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.847 0.356 . . . . 0.0 110.51 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.444 ' H ' ' C ' ' A' ' 23' ' ' GLY . . . 76.03 -70.56 2.05 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 55.9 m -69.65 169.75 12.15 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.125 0.488 . . . . 0.0 110.71 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.45 ' O ' ' O ' ' A' ' 63' ' ' ILE . 6.3 pt -138.25 165.54 25.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.304 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.469 HG23 HG22 ' A' ' 62' ' ' THR . 0.2 OUTLIER -87.7 -170.4 2.99 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.073 179.954 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.432 ' H ' HG22 ' A' ' 28' ' ' THR . 60.3 t -79.79 -36.36 17.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.51 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.504 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 96.6 mt-10 -65.04 -50.34 66.58 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.628 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -42.12 -62.62 0.9 Allowed 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.51 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.582 HD13 ' O ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -59.99 -39.79 86.95 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.453 -179.436 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.504 ' HB3' ' O ' ' A' ' 30' ' ' GLU . . . -43.98 -68.25 0.21 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.011 0.434 . . . . 0.0 110.435 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.9 m -49.2 -51.38 33.28 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.781 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 91.7 t -50.6 -30.6 8.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.609 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.522 HD13 HD12 ' A' ' 32' ' ' LEU . 1.0 OUTLIER -69.03 -34.58 64.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.48 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -68.79 -42.69 77.03 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.868 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.1 p -67.52 -39.75 85.07 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.73 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.462 ' O ' ' N ' ' A' ' 41' ' ' GLN . 51.4 mt -60.45 125.01 22.08 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.912 0.387 . . . . 0.0 110.129 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -65.07 66.27 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.801 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.483 ' C ' ' ND2' ' A' ' 42' ' ' ASN . 37.0 tt0 -140.0 172.88 12.13 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.241 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.49 ' ND2' ' N ' ' A' ' 42' ' ' ASN . 0.4 OUTLIER -142.76 67.37 18.52 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-O 120.871 0.367 . . . . 0.0 110.484 179.992 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -83.24 143.15 11.11 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.743 2.296 . . . . 0.0 111.956 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 22.9 p -64.28 130.71 44.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.269 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -71.35 -37.06 71.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.726 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -49.57 -42.32 44.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.341 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -58.38 -58.8 6.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.552 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.469 ' N ' HD12 ' A' ' 48' ' ' LEU . 9.6 mp -43.07 -46.04 5.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.599 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -57.92 -48.22 80.54 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.756 -0.377 . . . . 0.0 110.306 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -64.55 -50.81 65.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.071 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.557 ' O ' ' N ' ' A' ' 55' ' ' VAL . 87.1 mmm -63.08 -65.88 0.62 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.725 0.298 . . . . 0.0 111.153 -179.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 38.3 mm -43.54 -46.46 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.506 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.3 t -74.75 -20.56 59.77 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.606 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.496 ' N ' ' O ' ' A' ' 51' ' ' MET . 36.5 tt0 -106.38 7.89 31.37 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.787 0.327 . . . . 0.0 110.647 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.557 ' N ' ' O ' ' A' ' 51' ' ' MET . 71.8 t -123.82 -34.34 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 120.836 0.35 . . . . 0.0 110.495 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -55.6 85.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.595 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.473 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -72.03 -50.88 24.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.432 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.429 ' OD2' ' OE2' ' A' ' 64' ' ' GLU . 12.3 m-20 -45.74 -27.17 0.76 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.498 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.13 9.96 85.4 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.519 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 41.9 p30 -90.68 -0.83 57.82 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.807 0.337 . . . . 0.0 110.514 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 63.53 46.56 92.09 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.519 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 80.9 p -138.79 158.74 43.66 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.934 0.397 . . . . 0.0 110.338 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.45 ' O ' ' O ' ' A' ' 27' ' ' ILE . 87.4 mt -94.39 146.74 6.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.275 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.443 ' H ' ' HB2' ' A' ' 67' ' ' GLU . 78.9 mt-10 -140.33 -179.85 6.23 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.326 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -53.24 -79.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.557 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -43.99 -53.43 6.24 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.499 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.443 ' HB2' ' H ' ' A' ' 64' ' ' GLU . 96.6 mt-10 -49.43 -38.89 30.9 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.601 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 70.0 t80 . . . . . 0 C--N 1.326 -0.417 0 CA-C-O 120.923 0.392 . . . . 0.0 110.783 -179.967 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 19.1 mt . . . . . 0 CA--C 1.521 -0.142 0 CA-C-O 120.9 0.381 . . . . 0.0 110.325 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.412 ' O ' ' N ' ' A' ' 8' ' ' GLN . 0.3 OUTLIER -96.88 124.82 40.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.414 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.459 ' O ' ' N ' ' A' ' 9' ' ' ILE . 80.3 tt0 -37.67 -71.42 0.08 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.36 0.6 . . . . 0.0 111.535 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -46.64 -29.3 1.79 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.937 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.412 ' N ' ' O ' ' A' ' 5' ' ' SER . 45.4 tt0 -79.41 -25.67 42.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.579 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.459 ' N ' ' O ' ' A' ' 6' ' ' GLU . 3.1 tp -66.84 -36.38 77.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.1 t -76.79 -44.5 32.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.58 -178.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -53.45 -50.91 64.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.655 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -66.08 -44.46 84.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.337 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -55.45 -43.86 75.83 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.792 0.33 . . . . 0.0 110.431 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 -57.7 -45.12 86.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.443 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.09 -30.32 68.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.478 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -69.74 -50.78 40.1 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.738 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -62.9 -32.57 84.37 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 45.6 mt -69.78 -40.29 76.13 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.819 -0.353 . . . . 0.0 110.479 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -86.55 -13.26 46.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.426 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -116.45 102.08 9.2 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.495 ' C ' ' N ' ' A' ' 23' ' ' GLY . 55.5 mtpt -109.97 -32.38 7.06 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.853 0.359 . . . . 0.0 110.552 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.467 ' C ' ' H ' ' A' ' 24' ' ' ASP . 29.5 p30 -46.71 -13.53 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.553 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.495 ' N ' ' C ' ' A' ' 21' ' ' LYS . . . 66.21 -5.78 1.93 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.467 ' H ' ' C ' ' A' ' 22' ' ' ASP . 51.2 p-10 -54.16 -10.11 0.33 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.794 0.331 . . . . 0.0 110.558 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.43 ' H ' ' C ' ' A' ' 23' ' ' GLY . . . 75.79 -71.78 1.86 Allowed Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 88.4 m -67.91 168.64 11.31 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.35 0.595 . . . . 0.0 110.445 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.431 ' O ' ' O ' ' A' ' 63' ' ' ILE . 6.8 pt -136.78 164.9 29.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.379 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.796 HG22 ' H ' ' A' ' 29' ' ' VAL . 27.0 m -86.87 178.51 6.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.483 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.796 ' H ' HG22 ' A' ' 28' ' ' THR . 93.5 t -72.57 -43.8 61.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.357 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.451 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 97.2 mt-10 -61.31 -48.12 82.81 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.325 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -42.13 -62.54 0.91 Allowed 'General case' 0 C--O 1.236 0.393 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.2 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.58 HD13 ' O ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -62.52 -40.41 96.68 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.462 -179.722 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' ' 30' ' ' GLU . . . -44.13 -67.67 0.26 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.234 0.54 . . . . 0.0 110.552 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.8 m -48.45 -51.41 27.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.686 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 86.0 t -51.21 -30.94 10.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.712 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.532 HD13 HD12 ' A' ' 32' ' ' LEU . 1.0 OUTLIER -67.19 -34.02 66.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.804 179.557 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -69.91 -41.56 74.51 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.642 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.2 p -68.07 -39.55 82.93 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.592 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.49 ' O ' ' N ' ' A' ' 41' ' ' GLN . 55.4 mt -60.54 124.82 21.5 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.242 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -64.04 66.9 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.76 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.49 ' N ' ' O ' ' A' ' 39' ' ' LEU . 36.3 tt0 -141.59 173.38 11.55 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.304 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.491 ' ND2' ' N ' ' A' ' 42' ' ' ASN . 0.3 OUTLIER -143.64 67.59 16.22 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.543 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -82.81 143.86 12.0 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.772 2.315 . . . . 0.0 112.138 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 47.2 p -66.08 131.44 46.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.383 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -72.4 -35.33 68.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.676 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.91 -43.46 49.65 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.545 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -57.92 -58.72 7.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.581 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.482 ' N ' HD12 ' A' ' 48' ' ' LEU . 9.7 mp -44.3 -46.28 9.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.481 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -57.95 -46.66 84.74 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.515 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -64.56 -51.14 64.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.038 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.549 ' O ' ' N ' ' A' ' 55' ' ' VAL . 79.6 mmm -62.81 -64.15 1.0 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.053 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 32.1 mm -42.76 -47.96 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.654 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 37.8 t -72.16 -21.62 61.42 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.65 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.512 ' N ' ' O ' ' A' ' 51' ' ' MET . 51.1 tt0 -106.76 9.56 31.06 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.741 0.305 . . . . 0.0 110.536 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.549 ' N ' ' O ' ' A' ' 51' ' ' MET . 78.7 t -124.03 -38.95 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-O 120.777 0.322 . . . . 0.0 110.485 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -53.54 85.66 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.646 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -76.96 -45.86 26.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.478 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -51.06 -32.14 20.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.554 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 80.51 8.57 87.42 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.526 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 34.4 p-10 -87.31 -3.26 59.03 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.768 0.318 . . . . 0.0 110.561 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 64.35 47.12 87.79 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.526 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 79.3 p -142.76 153.45 43.3 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.881 0.372 . . . . 0.0 110.536 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.431 ' O ' ' O ' ' A' ' 27' ' ' ILE . 97.5 mt -88.51 155.61 3.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.207 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.448 ' H ' ' HB2' ' A' ' 67' ' ' GLU . 21.6 mt-10 -145.86 -178.33 6.05 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.428 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -53.71 -76.61 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.382 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -46.19 -54.82 8.05 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.972 -0.291 . . . . 0.0 110.663 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.448 ' HB2' ' H ' ' A' ' 64' ' ' GLU . 93.8 mt-10 -50.31 -40.62 49.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.903 0.383 . . . . 0.0 110.638 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 87.5 t80 . . . . . 0 C--N 1.329 -0.322 0 CA-C-O 121.058 0.456 . . . . 0.0 110.796 -179.967 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 52.5 mt . . . . . 0 N--CA 1.456 -0.14 0 CA-C-O 120.862 0.363 . . . . 0.0 110.228 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.443 ' O ' ' N ' ' A' ' 8' ' ' GLN . 0.2 OUTLIER -100.13 126.11 46.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.452 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.446 ' O ' ' N ' ' A' ' 9' ' ' ILE . 80.2 tt0 -36.73 -72.3 0.06 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.219 0.533 . . . . 0.0 111.485 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -46.78 -28.91 1.69 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.887 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.443 ' N ' ' O ' ' A' ' 5' ' ' SER . 44.4 tt0 -79.94 -26.32 40.14 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.608 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.446 ' N ' ' O ' ' A' ' 6' ' ' GLU . 3.2 tp -66.64 -35.64 75.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.0 t -77.48 -44.37 29.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.61 -179.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -54.06 -50.44 66.74 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.606 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -66.64 -44.35 82.18 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.397 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -56.12 -43.11 77.87 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.478 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.4 tp10 -59.28 -45.54 90.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.413 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.29 -32.71 73.05 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.426 179.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.414 ' O ' ' N ' ' A' ' 20' ' ' ASP . 33.9 t80 -68.61 -48.57 63.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.605 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -63.04 -32.22 83.38 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 45.8 mt -70.37 -39.23 74.71 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.575 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -88.66 -14.8 36.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.481 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 16' ' ' PHE . 29.7 t70 -115.57 102.17 9.54 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.594 -0.275 . . . . 0.0 110.315 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.492 ' C ' ' N ' ' A' ' 23' ' ' GLY . 55.1 mtpt -112.53 -30.06 7.26 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.833 0.349 . . . . 0.0 110.529 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.476 ' C ' ' H ' ' A' ' 24' ' ' ASP . 34.2 p30 -45.78 -15.14 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.55 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.492 ' N ' ' C ' ' A' ' 21' ' ' LYS . . . 66.7 -6.65 1.81 Allowed Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.476 ' H ' ' C ' ' A' ' 22' ' ' ASP . 50.0 p-10 -53.96 -10.68 0.35 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.836 0.351 . . . . 0.0 110.499 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.419 ' H ' ' C ' ' A' ' 23' ' ' GLY . . . 75.56 -71.88 1.79 Allowed Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 59.3 m -67.93 168.48 11.66 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.148 0.499 . . . . 0.0 110.485 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.465 ' CD1' HD23 ' A' ' 32' ' ' LEU . 3.7 pt -137.0 164.93 29.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.252 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.438 HG23 HG22 ' A' ' 62' ' ' THR . 0.2 OUTLIER -88.76 -174.43 4.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.253 -179.854 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.431 ' H ' HG22 ' A' ' 28' ' ' THR . 86.5 t -78.44 -37.44 21.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.339 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.5 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 96.7 mt-10 -65.64 -50.88 63.37 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.594 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -41.79 -61.34 1.13 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.409 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.582 HD13 ' O ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -61.06 -39.99 91.95 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.598 -179.546 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' A' ' 30' ' ' GLU . . . -43.74 -68.2 0.22 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.136 0.494 . . . . 0.0 110.623 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 16.2 m -48.62 -51.62 27.19 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.667 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 81.2 t -50.61 -31.44 9.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.728 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.54 HD13 HD12 ' A' ' 32' ' ' LEU . 1.0 OUTLIER -67.65 -33.56 62.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.708 179.52 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -70.25 -42.14 72.59 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.643 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.0 p -67.47 -39.41 85.29 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.514 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.477 ' O ' ' N ' ' A' ' 41' ' ' GLN . 55.7 mt -61.06 123.4 17.55 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.99 0.424 . . . . 0.0 110.232 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -64.22 67.17 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.723 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.477 ' N ' ' O ' ' A' ' 39' ' ' LEU . 36.7 tt0 -140.73 173.24 11.68 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.259 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.473 ' ND2' ' C ' ' A' ' 41' ' ' GLN . 0.5 OUTLIER -143.61 67.8 16.4 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.418 179.919 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -82.99 143.72 11.67 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.831 2.354 . . . . 0.0 112.071 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 49.4 p -66.11 132.4 48.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.192 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -72.54 -33.92 67.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.638 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -52.15 -44.83 64.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.409 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -57.57 -59.83 4.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.624 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.436 ' N ' HD12 ' A' ' 48' ' ' LEU . 9.7 mp -44.09 -45.99 8.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.408 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -58.05 -46.82 84.73 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.471 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -64.95 -50.99 64.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.089 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.555 ' O ' ' N ' ' A' ' 55' ' ' VAL . 80.5 mmm -62.95 -63.99 1.05 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.153 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 32.2 mm -42.79 -47.72 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.78 0.324 . . . . 0.0 110.719 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 37.3 t -72.29 -21.46 61.35 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.591 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.515 ' N ' ' O ' ' A' ' 51' ' ' MET . 53.0 tt0 -107.16 9.22 30.35 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.771 0.32 . . . . 0.0 110.626 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.555 ' N ' ' O ' ' A' ' 51' ' ' MET . 73.4 t -123.55 -37.68 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.338 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -54.71 85.49 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.922 0.391 . . . . 0.0 110.581 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.496 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -71.98 -49.97 32.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.52 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.419 ' OD2' ' OE2' ' A' ' 64' ' ' GLU . 10.9 m-20 -46.89 -28.8 1.71 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.436 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.97 9.74 86.57 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.522 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 44.4 p-10 -91.39 -0.44 57.64 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.83 0.348 . . . . 0.0 110.547 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 62.06 54.02 38.15 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.522 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 78.4 p -145.37 152.83 40.48 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.877 0.37 . . . . 0.0 110.452 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.425 ' O ' ' O ' ' A' ' 27' ' ' ILE . 97.1 mt -88.8 151.82 3.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.239 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.437 ' H ' ' HB2' ' A' ' 67' ' ' GLU . 35.0 mt-10 -146.08 -178.49 6.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.46 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -53.3 -77.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.501 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -46.09 -54.04 9.24 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.585 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.437 ' HB2' ' H ' ' A' ' 64' ' ' GLU . 95.0 mt-10 -50.24 -40.42 47.67 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.984 0.421 . . . . 0.0 110.659 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 86.5 t80 . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 120.989 0.423 . . . . 0.0 110.666 -179.984 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.482 ' CG ' ' H ' ' A' ' 3' ' ' ILE . 31.6 t70 -159.15 -178.38 7.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.288 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.482 ' H ' ' CG ' ' A' ' 2' ' ' ASP . 97.0 mt -134.93 150.91 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.268 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 48.2 mt -57.41 160.47 4.06 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.404 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.404 ' O ' ' N ' ' A' ' 8' ' ' GLN . 0.3 OUTLIER -92.99 125.91 37.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.449 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.467 ' O ' ' N ' ' A' ' 9' ' ' ILE . 80.7 tt0 -37.3 -72.47 0.06 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.281 0.562 . . . . 0.0 111.621 -179.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -47.51 -28.85 2.4 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.947 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.404 ' N ' ' O ' ' A' ' 5' ' ' SER . 44.9 tt0 -79.42 -24.65 42.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.399 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.467 ' N ' ' O ' ' A' ' 6' ' ' GLU . 3.4 tp -68.51 -36.92 76.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.3 t -75.23 -44.6 42.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.022 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -54.95 -50.24 69.39 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.642 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -66.52 -44.09 83.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.295 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -56.54 -42.74 78.99 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.404 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.9 tp10 -58.76 -46.09 88.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.367 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.92 -30.64 69.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.454 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -69.24 -48.95 60.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.853 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -65.82 -30.1 76.48 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 44.1 mt -72.74 -40.58 65.96 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.487 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -87.45 -15.2 38.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.481 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -113.82 101.82 9.64 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 110.213 -0.292 . . . . 0.0 110.213 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.505 ' O ' ' N ' ' A' ' 23' ' ' GLY . 55.2 mtpt -109.89 -31.68 7.32 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.011 0.434 . . . . 0.0 110.508 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.469 ' C ' ' H ' ' A' ' 24' ' ' ASP . 38.2 p30 -44.78 -15.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.554 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 21' ' ' LYS . . . 69.18 -10.15 1.9 Allowed Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.469 ' H ' ' C ' ' A' ' 22' ' ' ASP . 35.6 p-10 -50.37 -11.61 0.08 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.743 0.306 . . . . 0.0 110.476 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.469 ' H ' ' C ' ' A' ' 23' ' ' GLY . . . 75.8 -70.51 2.0 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 60.4 m -70.08 169.82 12.68 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.078 0.466 . . . . 0.0 110.767 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.44 ' O ' ' O ' ' A' ' 63' ' ' ILE . 6.3 pt -138.24 165.0 26.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.362 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 49.8 p -86.45 -170.95 3.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.493 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 72.5 t -79.44 -36.81 18.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.5 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.485 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 96.5 mt-10 -64.57 -50.02 68.88 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.733 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -42.24 -62.1 1.02 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.588 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.576 HD13 ' O ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -60.65 -39.65 89.13 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.475 -179.647 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' A' ' 30' ' ' GLU . . . -44.19 -67.98 0.24 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.11 0.481 . . . . 0.0 110.426 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 19.6 m -49.19 -51.4 33.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.749 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 89.7 t -50.79 -30.76 9.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.693 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.524 HD13 HD12 ' A' ' 32' ' ' LEU . 1.0 OUTLIER -68.42 -35.72 71.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.476 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -67.64 -42.74 81.77 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.628 -0.429 . . . . 0.0 111.022 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.1 p -67.82 -39.2 83.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.784 0.326 . . . . 0.0 110.897 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.454 ' O ' ' N ' ' A' ' 41' ' ' GLN . 52.7 mt -61.26 125.45 23.8 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.994 0.426 . . . . 0.0 109.999 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -65.22 66.19 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.826 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.485 ' C ' ' ND2' ' A' ' 42' ' ' ASN . 37.3 tt0 -140.48 173.55 11.39 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.146 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.485 ' ND2' ' C ' ' A' ' 41' ' ' GLN . 0.4 OUTLIER -143.33 67.34 16.69 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.749 0.309 . . . . 0.0 110.346 -179.89 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.41 ' HB2' ' HZ1' ' A' ' 75' ' ' LYS . 71.6 Cg_endo -83.13 143.06 11.2 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.681 2.254 . . . . 0.0 111.995 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 31.5 p -64.47 130.59 44.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.374 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -71.81 -36.61 70.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.63 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -49.2 -41.98 38.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.332 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -58.59 -57.6 12.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.498 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.486 ' N ' HD12 ' A' ' 48' ' ' LEU . 9.6 mp -43.62 -46.42 7.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.546 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -57.56 -48.59 78.92 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.295 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -64.07 -50.76 67.09 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.183 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.531 ' O ' ' N ' ' A' ' 55' ' ' VAL . 65.6 mmm -63.45 -65.46 0.68 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.33 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 39.1 mm -44.79 -46.59 2.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.3 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.3 t -73.55 -20.34 60.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.594 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' A' ' 51' ' ' MET . 34.6 tt0 -106.59 8.83 31.43 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.785 0.326 . . . . 0.0 110.701 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.531 ' N ' ' O ' ' A' ' 51' ' ' MET . 75.0 t -124.09 -36.49 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 120.811 0.339 . . . . 0.0 110.442 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.4 ' OD2' ' N ' ' A' ' 61' ' ' GLY . 32.4 t0 -54.35 86.15 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.628 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -73.89 -49.41 25.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.41 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.429 ' OD2' ' OE1' ' A' ' 64' ' ' GLU . 17.1 m-20 -48.94 -28.57 3.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.45 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.83 12.04 84.9 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.518 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 28.3 p30 -90.29 -0.77 57.78 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.783 0.325 . . . . 0.0 110.531 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.4 ' N ' ' OD2' ' A' ' 56' ' ' ASP . . . 64.16 40.83 98.4 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.518 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 54.4 p -136.93 152.23 49.95 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.848 0.356 . . . . 0.0 110.406 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.44 ' O ' ' O ' ' A' ' 27' ' ' ILE . 82.3 mt -87.89 153.07 3.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.342 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.443 ' H ' ' HB2' ' A' ' 67' ' ' GLU . 57.0 mt-10 -142.12 179.52 6.85 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.347 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -52.91 -79.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.475 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -44.46 -53.26 7.11 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.493 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.443 ' HB2' ' H ' ' A' ' 64' ' ' GLU . 95.7 mt-10 -49.04 -38.0 22.5 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.719 179.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -73.44 -40.6 64.09 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.884 -0.327 . . . . 0.0 110.877 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 78.4 mt -65.98 -40.29 91.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.478 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 78.0 p -62.77 -42.56 99.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.522 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.3 tt -58.94 -39.84 82.85 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.67 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 80.4 mmm -72.01 -43.92 64.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.786 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -49.4 -45.59 46.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.779 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -80.89 -48.08 12.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.581 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.41 ' HZ1' ' HB2' ' A' ' 43' ' ' PRO . 86.3 tttt -60.18 -56.25 23.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.577 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 42.9 t . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.489 179.897 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.474 ' CG ' ' H ' ' A' ' 3' ' ' ILE . 44.9 t0 -160.14 -178.64 7.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.307 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.474 ' H ' ' CG ' ' A' ' 2' ' ' ASP . 97.1 mt -135.47 150.12 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.355 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 46.6 mt -56.65 167.08 0.79 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.396 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.432 ' O ' ' N ' ' A' ' 8' ' ' GLN . 0.2 OUTLIER -99.8 126.7 45.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.36 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.443 ' O ' ' N ' ' A' ' 9' ' ' ILE . 80.2 tt0 -36.69 -72.11 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.138 0.494 . . . . 0.0 111.571 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -47.71 -28.54 2.5 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.929 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.432 ' N ' ' O ' ' A' ' 5' ' ' SER . 44.0 tt0 -79.76 -25.99 40.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.475 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.443 ' N ' ' O ' ' A' ' 6' ' ' GLU . 3.2 tp -67.25 -36.27 76.27 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 61.7 t -76.02 -44.36 37.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.913 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -55.2 -49.87 70.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.743 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -66.93 -43.97 81.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.365 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -57.04 -42.72 80.98 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.815 0.34 . . . . 0.0 110.366 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.1 tp10 -58.96 -45.13 91.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.377 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.8 -31.6 70.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.43 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.421 ' O ' ' N ' ' A' ' 20' ' ' ASP . 28.9 t80 -69.01 -49.76 54.85 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.814 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -63.66 -31.58 81.25 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 46.5 mt -71.8 -40.03 69.47 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.48 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -87.29 -15.83 36.9 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.513 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.421 ' N ' ' O ' ' A' ' 16' ' ' PHE . 30.2 t70 -114.06 102.19 9.94 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 179.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.496 ' O ' ' N ' ' A' ' 23' ' ' GLY . 55.5 mtpt -110.45 -31.23 7.34 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.942 0.401 . . . . 0.0 110.547 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.48 ' C ' ' H ' ' A' ' 24' ' ' ASP . 35.8 p30 -45.19 -15.61 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.575 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 21' ' ' LYS . . . 68.47 -8.96 1.92 Allowed Glycine 0 CA--C 1.523 0.54 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.48 ' H ' ' C ' ' A' ' 22' ' ' ASP . 43.6 p-10 -51.93 -11.6 0.17 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.86 0.362 . . . . 0.0 110.545 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.439 ' H ' ' C ' ' A' ' 23' ' ' GLY . . . 75.34 -70.49 1.88 Allowed Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 57.3 m -69.29 169.19 12.69 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.177 0.513 . . . . 0.0 110.579 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.7 pt -138.43 165.06 25.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.18 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.508 HG23 HG22 ' A' ' 62' ' ' THR . 0.2 OUTLIER -87.28 -171.23 3.38 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.117 179.946 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.427 ' H ' HG22 ' A' ' 28' ' ' THR . 59.1 t -79.08 -37.25 19.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.458 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.486 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 97.1 mt-10 -64.0 -50.22 69.36 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.669 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -42.25 -62.27 0.99 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.542 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.579 HD13 ' O ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -60.56 -39.54 88.34 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.47 -179.644 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.486 ' HB3' ' O ' ' A' ' 30' ' ' GLU . . . -44.52 -68.05 0.23 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.146 0.498 . . . . 0.0 110.317 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.6 m -48.62 -51.65 27.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.808 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 86.2 t -50.62 -31.87 9.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.694 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.53 HD13 HD12 ' A' ' 32' ' ' LEU . 1.0 OUTLIER -67.2 -35.58 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.566 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -68.03 -42.61 80.33 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.951 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.0 p -68.01 -38.68 82.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.87 0.367 . . . . 0.0 110.818 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.456 ' O ' ' N ' ' A' ' 41' ' ' GLN . 55.9 mt -61.41 124.15 19.82 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.912 0.386 . . . . 0.0 110.099 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -64.93 66.83 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.754 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.623 ' NE2' ' NZ ' ' A' ' 75' ' ' LYS . 37.2 tt0 -141.0 173.75 11.17 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.122 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.487 ' ND2' ' C ' ' A' ' 41' ' ' GLN . 0.4 OUTLIER -143.43 67.41 16.54 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.823 0.344 . . . . 0.0 110.419 -179.925 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -83.09 143.38 11.4 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.769 2.313 . . . . 0.0 112.096 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 40.6 p -65.87 132.41 48.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.345 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -72.16 -34.49 68.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.642 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -51.33 -44.55 62.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.453 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -57.28 -59.86 4.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.569 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.457 ' N ' HD12 ' A' ' 48' ' ' LEU . 9.6 mp -44.33 -46.06 9.08 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.467 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -57.9 -47.41 82.87 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.424 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -64.14 -50.77 66.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.158 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.554 ' O ' ' N ' ' A' ' 55' ' ' VAL . 77.2 mmm -63.67 -63.63 1.12 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.333 -179.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 31.3 mm -43.37 -47.42 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.336 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.8 t -71.92 -21.8 61.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.691 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.501 ' N ' ' O ' ' A' ' 51' ' ' MET . 53.2 tt0 -107.21 9.19 30.25 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 120.823 0.344 . . . . 0.0 110.578 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.554 ' N ' ' O ' ' A' ' 51' ' ' MET . 73.2 t -123.09 -38.38 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-O 120.839 0.352 . . . . 0.0 110.385 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -55.02 85.55 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.481 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -72.05 -50.05 31.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.447 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.427 ' OD2' ' OE2' ' A' ' 64' ' ' GLU . 17.4 m-20 -47.05 -28.59 1.76 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.412 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.83 10.33 86.12 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.934 -0.867 . . . . 0.0 110.934 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.52 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 36.3 p-10 -89.49 -1.87 58.18 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.773 0.32 . . . . 0.0 110.565 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 63.91 45.2 94.72 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.52 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 72.1 p -138.4 154.7 48.91 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.878 0.37 . . . . 0.0 110.549 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 87.8 mt -90.58 154.09 3.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.238 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.44 ' H ' ' HB2' ' A' ' 67' ' ' GLU . 54.4 mt-10 -146.48 -179.26 6.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.395 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -52.83 -78.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.541 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -44.62 -54.03 6.56 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.62 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.44 ' HB2' ' H ' ' A' ' 64' ' ' GLU . 98.2 mt-10 -50.25 -39.57 45.31 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.77 0.319 . . . . 0.0 110.668 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -71.04 -43.06 68.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.914 0.388 . . . . 0.0 110.83 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.0 mt -62.8 -37.02 85.05 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.31 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.405 ' OG ' ' O ' ' A' ' 67' ' ' GLU . 78.0 p -63.14 -43.15 99.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.48 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.0 tt -57.34 -40.82 78.79 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.614 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.428 ' O ' ' N ' ' A' ' 76' ' ' VAL . 80.8 mmm -70.74 -41.9 71.21 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.628 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -47.83 -44.56 29.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.567 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.1 mtpt -80.49 -50.31 10.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.615 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.623 ' NZ ' ' NE2' ' A' ' 41' ' ' GLN . 87.1 tttt -58.58 -56.82 17.2 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.502 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.428 ' N ' ' O ' ' A' ' 72' ' ' MET . 46.6 t . . . . . 0 C--O 1.221 -0.43 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.535 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.473 ' CG ' ' H ' ' A' ' 3' ' ' ILE . 44.7 t0 -160.14 -179.77 8.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.395 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.473 ' H ' ' CG ' ' A' ' 2' ' ' ASP . 97.1 mt -134.94 151.64 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-O 120.95 0.405 . . . . 0.0 110.363 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 50.0 mt -57.33 163.19 2.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.384 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.425 ' O ' ' N ' ' A' ' 8' ' ' GLN . 0.3 OUTLIER -95.43 125.5 40.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.43 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.467 ' O ' ' N ' ' A' ' 9' ' ' ILE . 80.4 tt0 -37.18 -72.21 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.149 0.5 . . . . 0.0 111.455 -179.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -47.13 -29.0 2.01 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.91 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.425 ' N ' ' O ' ' A' ' 5' ' ' SER . 45.4 tt0 -79.79 -24.72 41.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.518 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.467 ' N ' ' O ' ' A' ' 6' ' ' GLU . 3.2 tp -68.23 -36.27 74.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.8 t -76.33 -44.9 35.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.834 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -54.36 -50.23 67.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.731 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -66.34 -43.6 85.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.352 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -56.8 -42.68 79.93 Favored 'General case' 0 C--N 1.328 -0.37 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.427 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.3 tp10 -58.78 -45.97 88.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.419 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.99 -30.53 68.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.456 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -69.33 -49.25 57.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.768 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -65.23 -30.4 77.7 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 44.1 mt -72.57 -40.51 66.58 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.537 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -87.86 -14.93 38.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.439 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -113.81 101.81 9.64 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 179.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.505 ' O ' ' N ' ' A' ' 23' ' ' GLY . 55.8 mtpt -110.2 -31.35 7.36 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.859 0.362 . . . . 0.0 110.489 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.471 ' C ' ' H ' ' A' ' 24' ' ' ASP . 35.9 p30 -44.9 -15.58 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.565 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 21' ' ' LYS . . . 68.96 -9.7 1.91 Allowed Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.471 ' H ' ' C ' ' A' ' 22' ' ' ASP . 42.0 p-10 -51.25 -11.95 0.12 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.847 0.356 . . . . 0.0 110.51 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.444 ' H ' ' C ' ' A' ' 23' ' ' GLY . . . 76.03 -70.56 2.05 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 55.9 m -69.65 169.75 12.15 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.125 0.488 . . . . 0.0 110.71 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.45 ' O ' ' O ' ' A' ' 63' ' ' ILE . 6.3 pt -138.25 165.54 25.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.304 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.469 HG23 HG22 ' A' ' 62' ' ' THR . 0.2 OUTLIER -87.7 -170.4 2.99 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.073 179.954 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.432 ' H ' HG22 ' A' ' 28' ' ' THR . 60.3 t -79.79 -36.36 17.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.51 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.504 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 96.6 mt-10 -65.04 -50.34 66.58 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.628 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -42.12 -62.62 0.9 Allowed 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.51 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.582 HD13 ' O ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -59.99 -39.79 86.95 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.453 -179.436 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.504 ' HB3' ' O ' ' A' ' 30' ' ' GLU . . . -43.98 -68.25 0.21 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.011 0.434 . . . . 0.0 110.435 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.9 m -49.2 -51.38 33.28 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.781 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 91.7 t -50.6 -30.6 8.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.609 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.522 HD13 HD12 ' A' ' 32' ' ' LEU . 1.0 OUTLIER -69.03 -34.58 64.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.48 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -68.79 -42.69 77.03 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.868 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.1 p -67.52 -39.75 85.07 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.73 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.462 ' O ' ' N ' ' A' ' 41' ' ' GLN . 51.4 mt -60.45 125.01 22.08 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.912 0.387 . . . . 0.0 110.129 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -65.07 66.27 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.801 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.483 ' C ' ' ND2' ' A' ' 42' ' ' ASN . 37.0 tt0 -140.0 172.88 12.13 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.241 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.49 ' ND2' ' N ' ' A' ' 42' ' ' ASN . 0.4 OUTLIER -142.76 67.37 18.52 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-O 120.871 0.367 . . . . 0.0 110.484 179.992 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.416 ' HB3' ' HZ3' ' A' ' 75' ' ' LYS . 72.8 Cg_endo -83.24 143.15 11.11 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.743 2.296 . . . . 0.0 111.956 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 22.9 p -64.28 130.71 44.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.269 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -71.35 -37.06 71.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.726 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -49.57 -42.32 44.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.341 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -58.38 -58.8 6.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.552 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.469 ' N ' HD12 ' A' ' 48' ' ' LEU . 9.6 mp -43.07 -46.04 5.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.599 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -57.92 -48.22 80.54 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.756 -0.377 . . . . 0.0 110.306 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -64.55 -50.81 65.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.071 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.557 ' O ' ' N ' ' A' ' 55' ' ' VAL . 87.1 mmm -63.08 -65.88 0.62 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.725 0.298 . . . . 0.0 111.153 -179.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 38.3 mm -43.54 -46.46 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.506 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.3 t -74.75 -20.56 59.77 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.606 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.496 ' N ' ' O ' ' A' ' 51' ' ' MET . 36.5 tt0 -106.38 7.89 31.37 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.787 0.327 . . . . 0.0 110.647 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.557 ' N ' ' O ' ' A' ' 51' ' ' MET . 71.8 t -123.82 -34.34 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 120.836 0.35 . . . . 0.0 110.495 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -55.6 85.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.595 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.473 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -72.03 -50.88 24.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.432 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.429 ' OD2' ' OE2' ' A' ' 64' ' ' GLU . 12.3 m-20 -45.74 -27.17 0.76 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.498 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.13 9.96 85.4 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.519 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 41.9 p30 -90.68 -0.83 57.82 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.807 0.337 . . . . 0.0 110.514 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 63.53 46.56 92.09 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.519 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 80.9 p -138.79 158.74 43.66 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.934 0.397 . . . . 0.0 110.338 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.45 ' O ' ' O ' ' A' ' 27' ' ' ILE . 87.4 mt -94.39 146.74 6.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.275 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.443 ' H ' ' HB2' ' A' ' 67' ' ' GLU . 78.9 mt-10 -140.33 -179.85 6.23 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.326 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -53.24 -79.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.557 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -43.99 -53.43 6.24 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.499 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.443 ' HB2' ' H ' ' A' ' 64' ' ' GLU . 96.6 mt-10 -49.43 -38.89 30.9 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.601 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -72.71 -41.07 65.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.923 0.392 . . . . 0.0 110.783 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 80.6 mt -65.81 -40.02 91.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.458 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 77.7 p -62.17 -42.76 99.58 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.098 0.475 . . . . 0.0 110.473 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.3 tt -59.26 -39.6 83.36 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.721 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 79.9 mmm -72.44 -44.74 61.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.778 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -49.06 -46.28 44.2 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.884 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -80.7 -49.13 11.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.695 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.416 ' HZ3' ' HB3' ' A' ' 43' ' ' PRO . 87.6 tttt -58.27 -55.45 34.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.678 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 43.7 t . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.473 179.913 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.475 ' CG ' ' H ' ' A' ' 3' ' ' ILE . 29.1 t70 -160.03 -177.25 6.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.281 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.475 ' H ' ' CG ' ' A' ' 2' ' ' ASP . 97.4 mt -135.35 149.62 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.407 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 19.1 mt -57.69 165.41 1.68 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.325 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.412 ' O ' ' N ' ' A' ' 8' ' ' GLN . 0.3 OUTLIER -96.88 124.82 40.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.414 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.459 ' O ' ' N ' ' A' ' 9' ' ' ILE . 80.3 tt0 -37.67 -71.42 0.08 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.36 0.6 . . . . 0.0 111.535 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -46.64 -29.3 1.79 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.937 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.412 ' N ' ' O ' ' A' ' 5' ' ' SER . 45.4 tt0 -79.41 -25.67 42.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.579 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.459 ' N ' ' O ' ' A' ' 6' ' ' GLU . 3.1 tp -66.84 -36.38 77.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.1 t -76.79 -44.5 32.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.58 -178.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -53.45 -50.91 64.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.655 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -66.08 -44.46 84.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.337 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -55.45 -43.86 75.83 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.792 0.33 . . . . 0.0 110.431 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 -57.7 -45.12 86.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.443 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.09 -30.32 68.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.478 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -69.74 -50.78 40.1 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.738 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -62.9 -32.57 84.37 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 45.6 mt -69.78 -40.29 76.13 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.819 -0.353 . . . . 0.0 110.479 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -86.55 -13.26 46.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.426 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -116.45 102.08 9.2 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.495 ' C ' ' N ' ' A' ' 23' ' ' GLY . 55.5 mtpt -109.97 -32.38 7.06 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.853 0.359 . . . . 0.0 110.552 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.467 ' C ' ' H ' ' A' ' 24' ' ' ASP . 29.5 p30 -46.71 -13.53 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.553 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.495 ' N ' ' C ' ' A' ' 21' ' ' LYS . . . 66.21 -5.78 1.93 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.467 ' H ' ' C ' ' A' ' 22' ' ' ASP . 51.2 p-10 -54.16 -10.11 0.33 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.794 0.331 . . . . 0.0 110.558 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.43 ' H ' ' C ' ' A' ' 23' ' ' GLY . . . 75.79 -71.78 1.86 Allowed Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 88.4 m -67.91 168.64 11.31 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.35 0.595 . . . . 0.0 110.445 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.431 ' O ' ' O ' ' A' ' 63' ' ' ILE . 6.8 pt -136.78 164.9 29.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.379 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.796 HG22 ' H ' ' A' ' 29' ' ' VAL . 27.0 m -86.87 178.51 6.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.483 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.796 ' H ' HG22 ' A' ' 28' ' ' THR . 93.5 t -72.57 -43.8 61.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.357 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.451 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 97.2 mt-10 -61.31 -48.12 82.81 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.325 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -42.13 -62.54 0.91 Allowed 'General case' 0 C--O 1.236 0.393 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.2 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.58 HD13 ' O ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -62.52 -40.41 96.68 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.462 -179.722 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' ' 30' ' ' GLU . . . -44.13 -67.67 0.26 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.234 0.54 . . . . 0.0 110.552 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.8 m -48.45 -51.41 27.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.686 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 86.0 t -51.21 -30.94 10.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.712 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.532 HD13 HD12 ' A' ' 32' ' ' LEU . 1.0 OUTLIER -67.19 -34.02 66.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.804 179.557 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -69.91 -41.56 74.51 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.642 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.2 p -68.07 -39.55 82.93 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.592 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.49 ' O ' ' N ' ' A' ' 41' ' ' GLN . 55.4 mt -60.54 124.82 21.5 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.242 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -64.04 66.9 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.76 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.616 ' NE2' ' NZ ' ' A' ' 75' ' ' LYS . 36.3 tt0 -141.59 173.38 11.55 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.304 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.491 ' ND2' ' N ' ' A' ' 42' ' ' ASN . 0.3 OUTLIER -143.64 67.59 16.22 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.543 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -82.81 143.86 12.0 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.772 2.315 . . . . 0.0 112.138 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 47.2 p -66.08 131.44 46.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.383 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -72.4 -35.33 68.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.676 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.91 -43.46 49.65 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.545 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -57.92 -58.72 7.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.581 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.482 ' N ' HD12 ' A' ' 48' ' ' LEU . 9.7 mp -44.3 -46.28 9.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.481 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -57.95 -46.66 84.74 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.515 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -64.56 -51.14 64.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.038 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.549 ' O ' ' N ' ' A' ' 55' ' ' VAL . 79.6 mmm -62.81 -64.15 1.0 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.053 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 32.1 mm -42.76 -47.96 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.654 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 37.8 t -72.16 -21.62 61.42 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.65 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.512 ' N ' ' O ' ' A' ' 51' ' ' MET . 51.1 tt0 -106.76 9.56 31.06 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.741 0.305 . . . . 0.0 110.536 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.549 ' N ' ' O ' ' A' ' 51' ' ' MET . 78.7 t -124.03 -38.95 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-O 120.777 0.322 . . . . 0.0 110.485 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -53.54 85.66 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.646 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -76.96 -45.86 26.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.478 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -51.06 -32.14 20.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.554 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 80.51 8.57 87.42 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.526 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 34.4 p-10 -87.31 -3.26 59.03 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.768 0.318 . . . . 0.0 110.561 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 64.35 47.12 87.79 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.526 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 79.3 p -142.76 153.45 43.3 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.881 0.372 . . . . 0.0 110.536 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.431 ' O ' ' O ' ' A' ' 27' ' ' ILE . 97.5 mt -88.51 155.61 3.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.207 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.448 ' H ' ' HB2' ' A' ' 67' ' ' GLU . 21.6 mt-10 -145.86 -178.33 6.05 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.428 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -53.71 -76.61 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.382 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -46.19 -54.82 8.05 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.972 -0.291 . . . . 0.0 110.663 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.448 ' HB2' ' H ' ' A' ' 64' ' ' GLU . 93.8 mt-10 -50.31 -40.62 49.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.903 0.383 . . . . 0.0 110.638 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -70.76 -43.47 68.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.058 0.456 . . . . 0.0 110.796 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 46.7 mt -63.01 -37.21 86.27 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.322 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' A' ' 67' ' ' GLU . 77.7 p -62.44 -43.03 99.81 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.237 0.541 . . . . 0.0 110.37 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.6 tt -57.43 -39.86 77.14 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.643 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 81.0 mmm -71.15 -41.16 70.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.616 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -48.91 -44.08 39.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.539 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 31.0 mtpt -80.42 -50.39 10.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.625 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.616 ' NZ ' ' NE2' ' A' ' 41' ' ' GLN . 87.0 tttt -58.06 -56.49 21.31 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.471 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.9 t . . . . . 0 C--O 1.221 -0.438 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.677 179.991 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.463 ' CG ' ' H ' ' A' ' 3' ' ' ILE . 44.8 t0 -158.61 -178.94 7.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.272 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.463 ' H ' ' CG ' ' A' ' 2' ' ' ASP . 97.2 mt -135.36 149.25 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.416 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 52.5 mt -55.83 167.64 0.55 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.228 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.443 ' O ' ' N ' ' A' ' 8' ' ' GLN . 0.2 OUTLIER -100.13 126.11 46.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.452 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.446 ' O ' ' N ' ' A' ' 9' ' ' ILE . 80.2 tt0 -36.73 -72.3 0.06 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.219 0.533 . . . . 0.0 111.485 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -46.78 -28.91 1.69 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.887 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.443 ' N ' ' O ' ' A' ' 5' ' ' SER . 44.4 tt0 -79.94 -26.32 40.14 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.608 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.446 ' N ' ' O ' ' A' ' 6' ' ' GLU . 3.2 tp -66.64 -35.64 75.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.0 t -77.48 -44.37 29.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.61 -179.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -54.06 -50.44 66.74 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.606 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -66.64 -44.35 82.18 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.397 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -56.12 -43.11 77.87 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.478 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.4 tp10 -59.28 -45.54 90.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.413 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.29 -32.71 73.05 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.426 179.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.414 ' O ' ' N ' ' A' ' 20' ' ' ASP . 33.9 t80 -68.61 -48.57 63.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.605 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -63.04 -32.22 83.38 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 45.8 mt -70.37 -39.23 74.71 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.575 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -88.66 -14.8 36.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.481 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 16' ' ' PHE . 29.7 t70 -115.57 102.17 9.54 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.594 -0.275 . . . . 0.0 110.315 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.492 ' C ' ' N ' ' A' ' 23' ' ' GLY . 55.1 mtpt -112.53 -30.06 7.26 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.833 0.349 . . . . 0.0 110.529 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.476 ' C ' ' H ' ' A' ' 24' ' ' ASP . 34.2 p30 -45.78 -15.14 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.55 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.492 ' N ' ' C ' ' A' ' 21' ' ' LYS . . . 66.7 -6.65 1.81 Allowed Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.476 ' H ' ' C ' ' A' ' 22' ' ' ASP . 50.0 p-10 -53.96 -10.68 0.35 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.836 0.351 . . . . 0.0 110.499 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.419 ' H ' ' C ' ' A' ' 23' ' ' GLY . . . 75.56 -71.88 1.79 Allowed Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 59.3 m -67.93 168.48 11.66 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.148 0.499 . . . . 0.0 110.485 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.465 ' CD1' HD23 ' A' ' 32' ' ' LEU . 3.7 pt -137.0 164.93 29.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.252 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.438 HG23 HG22 ' A' ' 62' ' ' THR . 0.2 OUTLIER -88.76 -174.43 4.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.253 -179.854 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.431 ' H ' HG22 ' A' ' 28' ' ' THR . 86.5 t -78.44 -37.44 21.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.339 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.5 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 96.7 mt-10 -65.64 -50.88 63.37 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.594 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -41.79 -61.34 1.13 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.409 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.582 HD13 ' O ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -61.06 -39.99 91.95 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.598 -179.546 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' A' ' 30' ' ' GLU . . . -43.74 -68.2 0.22 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.136 0.494 . . . . 0.0 110.623 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 16.2 m -48.62 -51.62 27.19 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.667 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 81.2 t -50.61 -31.44 9.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.728 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.54 HD13 HD12 ' A' ' 32' ' ' LEU . 1.0 OUTLIER -67.65 -33.56 62.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.708 179.52 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -70.25 -42.14 72.59 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.643 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.0 p -67.47 -39.41 85.29 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.514 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.477 ' O ' ' N ' ' A' ' 41' ' ' GLN . 55.7 mt -61.06 123.4 17.55 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.99 0.424 . . . . 0.0 110.232 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -64.22 67.17 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.723 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.625 ' NE2' ' NZ ' ' A' ' 75' ' ' LYS . 36.7 tt0 -140.73 173.24 11.68 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.259 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.473 ' ND2' ' C ' ' A' ' 41' ' ' GLN . 0.5 OUTLIER -143.61 67.8 16.4 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.418 179.919 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -82.99 143.72 11.67 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.831 2.354 . . . . 0.0 112.071 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 49.4 p -66.11 132.4 48.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.192 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -72.54 -33.92 67.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.638 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -52.15 -44.83 64.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.409 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -57.57 -59.83 4.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.624 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.436 ' N ' HD12 ' A' ' 48' ' ' LEU . 9.7 mp -44.09 -45.99 8.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.408 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -58.05 -46.82 84.73 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.471 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -64.95 -50.99 64.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.089 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.555 ' O ' ' N ' ' A' ' 55' ' ' VAL . 80.5 mmm -62.95 -63.99 1.05 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.153 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 32.2 mm -42.79 -47.72 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.78 0.324 . . . . 0.0 110.719 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 37.3 t -72.29 -21.46 61.35 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.591 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.515 ' N ' ' O ' ' A' ' 51' ' ' MET . 53.0 tt0 -107.16 9.22 30.35 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.771 0.32 . . . . 0.0 110.626 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.555 ' N ' ' O ' ' A' ' 51' ' ' MET . 73.4 t -123.55 -37.68 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.338 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -54.71 85.49 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.922 0.391 . . . . 0.0 110.581 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.496 ' N ' ' O ' ' A' ' 55' ' ' VAL . . . -71.98 -49.97 32.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.52 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.419 ' OD2' ' OE2' ' A' ' 64' ' ' GLU . 10.9 m-20 -46.89 -28.8 1.71 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.436 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.97 9.74 86.57 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.522 ' ND2' ' OG1' ' A' ' 62' ' ' THR . 44.4 p-10 -91.39 -0.44 57.64 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.83 0.348 . . . . 0.0 110.547 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 62.06 54.02 38.15 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.522 ' OG1' ' ND2' ' A' ' 60' ' ' ASN . 78.4 p -145.37 152.83 40.48 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.877 0.37 . . . . 0.0 110.452 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.425 ' O ' ' O ' ' A' ' 27' ' ' ILE . 97.1 mt -88.8 151.82 3.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.239 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.437 ' H ' ' HB2' ' A' ' 67' ' ' GLU . 35.0 mt-10 -146.08 -178.49 6.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.46 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -53.3 -77.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.501 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -46.09 -54.04 9.24 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.585 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.437 ' HB2' ' H ' ' A' ' 64' ' ' GLU . 95.0 mt-10 -50.24 -40.42 47.67 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.984 0.421 . . . . 0.0 110.659 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -70.66 -43.13 69.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.989 0.423 . . . . 0.0 110.666 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 90.3 mt -62.45 -37.53 86.26 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.321 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.405 ' OG ' ' O ' ' A' ' 67' ' ' GLU . 77.8 p -62.71 -43.02 99.89 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.164 0.507 . . . . 0.0 110.464 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.7 tt -57.14 -40.67 77.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.618 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.426 ' O ' ' N ' ' A' ' 76' ' ' VAL . 79.3 mmm -70.87 -41.27 71.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.545 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -47.93 -44.74 30.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.628 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 29.7 mtpt -80.95 -50.46 9.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.652 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.625 ' NZ ' ' NE2' ' A' ' 41' ' ' GLN . 86.5 tttt -57.87 -56.38 22.7 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.468 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.426 ' N ' ' O ' ' A' ' 72' ' ' MET . 46.3 t . . . . . 0 C--O 1.221 -0.438 0 CA-C-O 117.906 -1.045 . . . . 0.0 110.526 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_